{"content":"<li class=\"n-box-item date-title\" data-end=\"1368244799\" data-start=\"1368158400\" data-txt=\"Friday, December 20, 2019\">Friday, May 10, 2013</li><li class=\"n-box-item sa-box-item\" data-id=\"1019721\" data-ts=\"1368222543\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BKNG\" target=\"_blank\">BKNG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1019721\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Though Priceline (PCLN +3.8%) rallied today in response to its Q1 report, acquisition target...</a></h4><p>Though Priceline (PCLN <font color=\"green\">+3.8%</font>) <a href=\"https://seekingalpha.com/currents/post/1019221\" target=\"_blank\">rallied today</a> in response to its Q1 report, acquisition target Kayak (<a href=\"https://seekingalpha.com/symbol/KYAK\" title=\"Kayak Software Corporation\">KYAK</a> <font color=\"red\">-3.4%</font>) slumped to $40.10. Priceline announced yesterday it has received \"all necessary regulatory approvals\" for the Kayak acquisition, and expects the deal to close on May 21. It looks as if investors are abandoning hope of an offer above the current $40/share (1/3 in cash, 2/3 in stock).</p><div class=\"tiny-share-widget\" data-id=\"1019721\" data-linked=\"Though Priceline (PCLN +3.8%) rallied today in response to its Q1 report, acquisition target...\" data-tweet=\"$BKNG $BKNG $KYAK - Though Priceline (PCLN +3.8%) rallied today in response to its Q1 report, acquisition target Kayak (KYAK -3.4%) slumped to $40.10. Priceline announced yesterday it has received &quot;all necessary regulatory approvals&quot; for the Kayak acqui... https://seekingalpha.com/news/1019721?source=tweet\" data-url=\"https://seekingalpha.com/news/1019721\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:49 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1019701\" data-ts=\"1368222424\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ENDP\" target=\"_blank\">ENDP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1019701\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After-hours top gainers, as of 5:30 p.m.: ENDP +3.6%. NVAX +2.8%. GRFS +2.7%. REE +2.6%. IMRS...</a></h4><b>After-hours top gainers, as of 5:30 p.m.:</b> <a href=\"https://seekingalpha.com/symbol/ENDP\" title=\"Endo International plc\">ENDP</a> <font color=\"green\">+3.6%</font>. <a href=\"https://seekingalpha.com/symbol/NVAX\" title=\"Novavax, Inc.\">NVAX</a> <font color=\"green\">+2.8%</font>. <a href=\"https://seekingalpha.com/symbol/GRFS\" title=\"Grifols S.A.\">GRFS</a> <font color=\"green\">+2.7%</font>. <a href=\"https://seekingalpha.com/symbol/REE\" title=\"Rare Element Resources Ltd.\">REE</a> <font color=\"green\">+2.6%</font>. <a href=\"https://seekingalpha.com/symbol/IMRS\" title=\"Imris Inc\">IMRS</a> <font color=\"green\">+2.4%</font>. <br> <b>AftTer-hours top losers:</b> <a href=\"https://seekingalpha.com/symbol/ET-OLD\" title=\"Energy Transfer LP\">ET-OLD</a> <font color=\"red\">-4.0%</font>. <a href=\"https://seekingalpha.com/symbol/APTS\" title=\"Preferred Apartment Communities\">APTS</a> <font color=\"red\">-3.7%</font>. <a href=\"https://seekingalpha.com/symbol/SYNC\" title=\"Synacor\">SYNC</a> <font color=\"red\">-3.6%</font>. <a href=\"https://seekingalpha.com/symbol/SSRI\" title=\"SSR Mining Inc\">SSRI</a> <font color=\"red\">-2.7%</font>. <a href=\"https://seekingalpha.com/symbol/VG\" title=\"Vonage Holdings Corp.\">VG</a> <font color=\"red\">-2.5%</font>.<div class=\"tiny-share-widget\" data-id=\"1019701\" data-linked=\"After-hours top gainers, as of 5:30 p.m.: ENDP +3.6%. NVAX +2.8%. GRFS +2.7%. REE +2.6%. IMRS...\" data-tweet=\"$ENDP $ENDP $NVAX - After-hours top gainers, as of 5:30 p.m.: ENDP +3.6%. NVAX +2.8%. GRFS +2.7%. REE +2.6%. IMRS +2.4%. AftTer-hours top losers: ET-OLD -4.0%. APTS -3.7%. SYNC -3.6%. SSRI -2.7%. VG -2.5%. https://seekingalpha.com/news/1019701?source=tweet\" data-url=\"https://seekingalpha.com/news/1019701\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:47 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1019641\" data-ts=\"1368218260\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRIN\" target=\"_blank\">MRIN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1019641\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Marin Software (MRIN -12.7%) has fallen 30% since posting a Q1 beat; shares are now down 29%...</a></h4><p>Marin Software (<a href=\"https://seekingalpha.com/symbol/MRIN\" title=\"Marin Software\">MRIN</a> <font color=\"red\">-12.7%</font>) has <font color=\"red\">fallen 30%</font> since posting a <a href=\"https://seekingalpha.com/currents/post/1010961\" target=\"_blank\">Q1 beat</a>; shares are now down 29% from March's $14 IPO price. Marin forecast Q2 revenue of $17.6M-$18M and EPS of -$0.31 to -$0.33 vs. a consensus of $17.8M and -$0.33, and 2013 revenue of $75M-$76.2M and EPS of -$1.19 to -$1.16 vs. a consensus of $74.4M and -$1.20. Aggressive spending is yielding big losses: Marin's opex rose 38% Y/Y in Q1 to $19.6M, above rev. growth of 32%. On the <a href=\"https://seekingalpha.com/article/1417091-marin-software-ceo-discusses-q1-2013-results-earnings-call-transcript\" target=\"_blank\">earnings call</a>, a UBS analyst raised questions about new deal activity slowing Y/Y, and Q/Q rev. growth slowing markedly from a year ago. Adobe (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ADBE\" title=\"Adobe Systems Incorporated\">ADBE</a>), whose <a href=\"http://www.adobe.com/products/adlens.html\" target=\"_blank\">AdLens unit</a> (formerly Efficient Frontier) is a major rival of Marin's, fell 3% yesterday.</p><div class=\"tiny-share-widget\" data-id=\"1019641\" data-linked=\"Marin Software (MRIN -12.7%) has fallen 30% since posting a Q1 beat; shares are now down 29%...\" data-tweet=\"$MRIN $MRIN $ADBE - Marin Software (MRIN -12.7%) has fallen 30% since posting a Q1 beat; shares are now down 29% from March&#39;s $14 IPO price. Marin forecast Q2 revenue of $17.6M-$18M and EPS of -$0.31 to -$0.33 vs. a consensus of $17.8M and -$0.33, and 2... https://seekingalpha.com/news/1019641?source=tweet\" data-url=\"https://seekingalpha.com/news/1019641\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:37 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1019591\" data-ts=\"1368217342\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1019591\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">The week&#39;s ETF movers - Gainers: REMX +10.8%. URA +6.6%. TAN +6.4%. VNM +5.4%. XHB +3.4%. ETF...</a></h4><b>The week's ETF movers - Gainers:</b> <a href='https://seekingalpha.com/symbol/remx' title='Market Vectors Rare Earth/Strategic Metals ETF'>REMX</a> <font color=\"green\">+10.8%</font>. <a href='https://seekingalpha.com/symbol/ura' title='Global X Uranium ETF'>URA</a> <font color=\"green\">+6.6%</font>. <a href='https://seekingalpha.com/symbol/tan' title='Guggenheim Solar ETF '>TAN</a> <font color=\"green\">+6.4%</font>. <a href='https://seekingalpha.com/symbol/vnm' title='Market Vectors Vietnam ETF'>VNM</a> <font color=\"green\">+5.4%</font>. <a href='https://seekingalpha.com/symbol/xhb' title='SPDR Homebuilders ETF'>XHB</a> <font color=\"green\">+3.4%</font>. <br /> <b>ETF Losers:</b> <a href='https://seekingalpha.com/symbol/gaz' title='iPath DJ-UBS Natural Gas Total Return Sub-Index ETN'>GAZ</a> <font color=\"red\">-4.5%</font>. <a href='https://seekingalpha.com/symbol/ung' title='The United States Natural Gas ETF, LP'>UNG</a> <font color=\"red\">-3.6%</font>. <a href='https://seekingalpha.com/symbol/fxa' title='CurrencyShares Australian Dollar Trust ETF'>FXA</a> <font color=\"red\">-3.0%</font>. <a href='https://seekingalpha.com/symbol/ewy' title='iShares MSCI South Korea Capped Index ETF'>EWY</a> <font color=\"red\">-2.7%</font>. <a href='https://seekingalpha.com/symbol/ewa' title='iShares MSCI Australia Index Fund'>EWA</a> <font color=\"red\">-2.7%</font>.<div class=\"tiny-share-widget\" data-id=\"1019591\" data-linked=\"The week&#39;s ETF movers - Gainers: REMX +10.8%. URA +6.6%. TAN +6.4%. VNM +5.4%. XHB +3.4%. ETF...\" data-tweet=\"$REMX $URA $TAN - The week&#39;s ETF movers - Gainers: REMX +10.8%. URA +6.6%. TAN +6.4%. VNM +5.4%. XHB +3.4%. ETF Losers: GAZ -4.5%. UNG -3.6%. FXA -3.0%. EWY -2.7%. EWA -2.7%. https://seekingalpha.com/news/1019591?source=tweet\" data-url=\"https://seekingalpha.com/news/1019591\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:22 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1019571\" data-ts=\"1368216912\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ENDP\" target=\"_blank\">ENDP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1019571\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Today&#39;s decision by the FDA on Endo&#39;s (ENDP -5.3%) Opana ER puts to rest an aggressive campaign...</a></h4><p>Today's <a href=\"http://www.streetinsider.com/FDA/FDA+Denies+Endo+%28ENDP%29+Petition+to+Block+Generic+Forms+of+Opana+ER/8327802.html\" target=\"_blank\">decision</a> by the FDA on Endo's (<a href=\"https://seekingalpha.com/symbol/ENDP\" title=\"Endo International plc\">ENDP</a> <font color=\"red\">-5.3%</font>) Opana ER puts to rest an aggressive campaign <a href=\"http://www.fdanews.com/newsletter/article?articleId=150188&amp;issueId=16216\" target=\"_blank\">begun</a> last October by the drug developer to keep generic versions off the market. In the end, the agency comes full circle, reiterating that the original formulation of Opana ER was not withdrawn for reasons of safety or effectiveness. Therefore, generic versions of the original formulation can continue to be approved and marketed. Following a brief resumption of trading just before the closing bell, the stock has since been halted a second time.</p><div class=\"tiny-share-widget\" data-id=\"1019571\" data-linked=\"Today&#39;s decision by the FDA on Endo&#39;s (ENDP -5.3%) Opana ER puts to rest an aggressive campaign...\" data-tweet=\"$ENDP - Today&#39;s decision by the FDA on Endo&#39;s (ENDP -5.3%) Opana ER puts to rest an aggressive campaign begun last October by the drug developer to keep generic versions off the market. In the end, the agency comes full circle, reiterating that the orig... https://seekingalpha.com/news/1019571?source=tweet\" data-url=\"https://seekingalpha.com/news/1019571\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:15 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1019561\" data-ts=\"1368216601\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVDA\" target=\"_blank\">NVDA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1019561\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">&quot;Nvidia&amp;rsquo;s (NVDA +4.5%) gross margin upside in a humbling quarter for Tegra and an...</a></h4><p>\"Nvidia\u2019s (<a href=\"https://seekingalpha.com/symbol/NVDA\" title=\"NVIDIA Corporation\">NVDA</a> <font color=\"green\">+4.5%</font>) <a href=\"https://seekingalpha.com/currents/post/1016061\" target=\"_blank\">gross margin upside</a> in a humbling quarter for Tegra and an 'apocalyptic' PC environment was quite impressive,\" <a href=\"http://blogs.barrons.com/techtraderdaily/2013/05/10/this-morning-msft-caught-in-fed-speak-ddd-slips-no-aapl-margin-meltdown/?mod=yahoobarrons\" target=\"_blank\">writes Raymond James</a> following the <a href=\"https://seekingalpha.com/currents/post/1015781\" target=\"_blank\">FQ1 report</a>. Judging by today's rally, many agree. RJ sees the margin strength as proof demand for high-end GPUs for gaming/computing/workstations \"is likely more inelastic than thought.\" Others are <a href=\"http://news.investors.com/technology/051013-655634-nvidia-ramps-new-tegra-for-mobile-devices.htm\" target=\"_blank\">worried about the Tegra unit</a>, which is losing share ahead of the Tegra 4 (FQ2/FQ3) and 4i (FQ4/FQ1) launches. On the <a href=\"https://seekingalpha.com/article/1422111-nvidia-s-ceo-discusses-f1q-2014-results-earnings-call-transcript\" target=\"_blank\">earnings call</a>, CEO Jen-Hsun Huang admitted Tegra's gross margin is below Nvidia's total GM, but added margins for <a href=\"https://seekingalpha.com/currents/post/897551\" target=\"_blank\">GRID</a> and <a href=\"http://www.nvidia.com/object/tesla-supercomputing-solutions.html\" target=\"_blank\">Tesla</a> (also expected to grow fast in 2H) are above-average. <a href=\"https://seekingalpha.com/symbol/AMD\" title=\"Advanced Micro Devices, Inc.\">AMD</a> <font color=\"green\">+2.3%</font>.</p><div class=\"tiny-share-widget\" data-id=\"1019561\" data-linked=\"&quot;Nvidia\u2019s (NVDA +4.5%) gross margin upside in a humbling quarter for Tegra and an &#39;apocalyptic&#39;...\" data-tweet=\"$NVDA $NVDA $AMD - &quot;Nvidia\u2019s (NVDA +4.5%) gross margin upside in a humbling quarter for Tegra and an &#39;apocalyptic&#39; PC environment was quite impressive,&quot; writes Raymond James following the FQ1 report. Judging by today&#39;s rally, many agree. RJ sees the mar... https://seekingalpha.com/news/1019561?source=tweet\" data-url=\"https://seekingalpha.com/news/1019561\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1019381\" data-ts=\"1368215415\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MNKD\" target=\"_blank\">MNKD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1019381\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">For Mankind (MNKD +10.3%) no bad news is good news today, as the stock rips higher following an...</a></h4><p>For Mankind (<a href=\"https://seekingalpha.com/symbol/MNKD\" title=\"MannKind Corporation\">MNKD</a> <font color=\"green\">+10.3%</font>) no bad news is good news today, as the stock rips higher following an inline <a href=\"https://seekingalpha.com/market_currents/post/1016491\" target=\"_blank\">Q1 report</a> late yesterday. Operating expenses rose by 9% Y/Y, primarily due to an increase in clinical trial related expenses.</p><div class=\"tiny-share-widget\" data-id=\"1019381\" data-linked=\"For Mankind (MNKD +10.3%) no bad news is good news today, as the stock rips higher following an...\" data-tweet=\"$MNKD - For Mankind (MNKD +10.3%) no bad news is good news today, as the stock rips higher following an inline Q1 report late yesterday. Operating expenses rose by 9% Y/Y, primarily due to an increase in clinical trial related expenses. https://seekingalpha.com/news/1019381?source=tweet\" data-url=\"https://seekingalpha.com/news/1019381\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1019371\" data-ts=\"1368215130\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PKI\" target=\"_blank\">PKI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1019371\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PerkinElmer (PKI +1.2%) introduces a new version of Lead Discovery for the Tibco Spotfire...</a></h4><p>PerkinElmer (<a href=\"https://seekingalpha.com/symbol/PKI\" title=\"PerkinElmer, Inc.\">PKI</a> <font color=\"green\">+1.2%</font>) introduces <a href=\"http://itsoftware.pharmaceutical-business-review.com/news/perkinelmer-introduces-new-intelligence-capabilities-for-tibco-spotfire-platform-100513\" target=\"_blank\">a new version</a> of Lead Discovery for the Tibco Spotfire software platform, which, when combined with the Tibco Spotfire software's advanced data visualization and analysis capabilities, brings a new level of chemical intelligence to the informatics platform for advanced scientific discovery. The new version, called Lead Discovery 5.1, uses <a href=\"https://seekingalpha.com/symbol/PKI\" title=\"PerkinElmer, Inc.\">PKI</a>'s ChemDraw drawing tool to improve the capabilities of data analysis with new functionality built to assist chemists.</p><div class=\"tiny-share-widget\" data-id=\"1019371\" data-linked=\"PerkinElmer (PKI +1.2%) introduces a new version of Lead Discovery for the Tibco Spotfire...\" data-tweet=\"$PKI - PerkinElmer (PKI +1.2%) introduces a new version of Lead Discovery for the Tibco Spotfire software platform, which, when combined with the Tibco Spotfire software&#39;s advanced data visualization and analysis capabilities, brings a new level of chem... https://seekingalpha.com/news/1019371?source=tweet\" data-url=\"https://seekingalpha.com/news/1019371\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1019361\" data-ts=\"1368214575\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ENDP\" target=\"_blank\">ENDP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1019361\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Endo Health (ENDP -3.6%) trade lower following a brief halt after the FDA denies its...</a></h4>Shares of Endo Health (<a href='https://seekingalpha.com/symbol/ENDP' title='Endo International plc'>ENDP</a> <font color=\"red\">-3.6%</font>) trade lower following a brief halt after the <a href=\"http://www.streetinsider.com/Trading+Halts/Endo+Pharma+%28ENDP%29+petition+to+block+generic+Opana+ER+denied+by+FDA+-+Bloomberg/8327705.html\" target=\"_blank\">FDA denies</a> its petition to block generic versions of its Opana ER. <a href='https://seekingalpha.com/symbol/ZGNX' title='Zogenix, Inc.'>ZGNX</a> <font color=\"green\">+2.1%</font>, IPXL <font color=\"green\">+8.4%</font>.<div class=\"tiny-share-widget\" data-id=\"1019361\" data-linked=\"Shares of Endo Health (ENDP -3.6%) trade lower following a brief halt after the FDA denies its...\" data-tweet=\"$ENDP $ENDP $ZGNX - Shares of Endo Health (ENDP -3.6%) trade lower following a brief halt after the FDA denies its petition to block generic versions of its Opana ER. ZGNX +2.1%, IPXL +8.4%. https://seekingalpha.com/news/1019361?source=tweet\" data-url=\"https://seekingalpha.com/news/1019361\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:36 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1019341\" data-ts=\"1368214333\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SFD\" target=\"_blank\">SFD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1019341\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Smithfield Foods (SFD +1.5%) trades higher after corn futures tumble on word that the corn...</a></h4><p>Smithfield Foods (<a href=\"https://seekingalpha.com/symbol/SFD\" title=\"Smithfield Foods Inc.\">SFD</a> <font color=\"green\">+1.5%</font>) trades higher after corn futures tumble on word that the <a href=\"https://seekingalpha.com/currents/post/1019021\" target=\"_blank\">corn harvest</a> in the fall could come in well-above expectations. Another company to watch is Archer Daniels Midland (<a href=\"https://seekingalpha.com/symbol/ADM\" title=\"Archer Daniels Midland Co.\">ADM</a> <font color=\"green\">+0.1%</font>) which buys corn to produce ethanol. (<a href=\"http://usda.mannlib.cornell.edu/MannUsda/viewDocumentInfo.do?documentID=1046\" target=\"_blank\">USDA report</a>)</p><div class=\"tiny-share-widget\" data-id=\"1019341\" data-linked=\"Smithfield Foods (SFD +1.5%) trades higher after corn futures tumble on word that the corn...\" data-tweet=\"$SFD $SFD $ADM - Smithfield Foods (SFD +1.5%) trades higher after corn futures tumble on word that the corn harvest in the fall could come in well-above expectations. Another company to watch is Archer Daniels Midland (ADM +0.1%) which buys corn to prod... https://seekingalpha.com/news/1019341?source=tweet\" data-url=\"https://seekingalpha.com/news/1019341\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:32 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1019331\" data-ts=\"1368214141\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ILMN\" target=\"_blank\">ILMN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1019331\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Illumina (ILMN +10%) ramp higher today, spiking up on heavy volume with no apparent...</a></h4>Shares of Illumina (<a href='https://seekingalpha.com/symbol/ILMN' title='Illumina, Inc.'>ILMN</a> <font color=\"green\">+10%</font>) ramp higher today, spiking up on heavy volume with no apparent news driving the move. Of note; <a target=\"_blank\" href=\"http://www.nasdaq.com/symbol/ilmn/short-interest\">short interest</a> in the stock continues to inch higher, but days to cover has plummeted as average daily volume in the shares has nearly doubled since March, bringing it back to nearly 2M shares per day, a level it hasn't seen since January - and perhaps an indication of piquing institutional interest.<div class=\"tiny-share-widget\" data-id=\"1019331\" data-linked=\"Shares of Illumina (ILMN +10%) ramp higher today, spiking up on heavy volume with no apparent...\" data-tweet=\"$ILMN - Shares of Illumina (ILMN +10%) ramp higher today, spiking up on heavy volume with no apparent news driving the move. Of note; short interest in the stock continues to inch higher, but days to cover has plummeted as average daily volume in the sh... https://seekingalpha.com/news/1019331?source=tweet\" data-url=\"https://seekingalpha.com/news/1019331\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:29 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1019311\" data-ts=\"1368212876\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AGN\" target=\"_blank\">AGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1019311\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Activis (ACT +11.4%) and Warner Chilcott (WCRX +24.2%) both resume trading.</a></h4>Shares of Activis (<a href='https://seekingalpha.com/symbol/ACT' title='AdvisorShares Vice ETF'>ACT</a> <font color=\"green\">+11.4%</font>) and Warner Chilcott (<a href='https://seekingalpha.com/symbol/WCRX' title='Warner Chilcott Limited'>WCRX</a> <font color=\"green\">+24.2%</font>) both resume trading.<div class=\"tiny-share-widget\" data-id=\"1019311\" data-linked=\"Shares of Activis (ACT +11.4%) and Warner Chilcott (WCRX +24.2%) both resume trading.\" data-tweet=\"$AGN $AGN $WCRX - Shares of Activis (ACT +11.4%) and Warner Chilcott (WCRX +24.2%) both resume trading. https://seekingalpha.com/news/1019311?source=tweet\" data-url=\"https://seekingalpha.com/news/1019311\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:07 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1019291\" data-ts=\"1368212557\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WCRX\" target=\"_blank\">WCRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1019291\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Activis (ACT +11.9) and Warner Chilcott (WCRX +11%) both remain halted after...</a></h4><p>Shares of Activis (ACT +11.9) and Warner Chilcott (<a href=\"https://seekingalpha.com/symbol/WCRX\" title=\"Warner Chilcott Limited\">WCRX</a> <font color=\"green\">+11%</font>) both remain halted after confirming they are in merger talks. Shares are due to resume trading shortly.</p><div class=\"tiny-share-widget\" data-id=\"1019291\" data-linked=\"Shares of Activis (ACT +11.9) and Warner Chilcott (WCRX +11%) both remain halted after...\" data-tweet=\"$WCRX - Shares of Activis (ACT +11.9) and Warner Chilcott (WCRX +11%) both remain halted after confirming they are in merger talks. Shares are due to resume trading shortly. https://seekingalpha.com/news/1019291?source=tweet\" data-url=\"https://seekingalpha.com/news/1019291\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1019261\" data-ts=\"1368211380\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ET-OLD\" target=\"_blank\">ET-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1019261\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Perpetually range-bound ExactTarget (ET-OLD -7.8%) falls hard after providing mixed guidance...</a></h4><a target=\"_blank\" href=\"http://finance.yahoo.com/q/bc?s=ET+Basic+Chart\">Perpetually range-bound</a> ExactTarget (<a href=\"https://seekingalpha.com/symbol/ET-OLD\" title=\"Energy Transfer LP\">ET-OLD</a> <font color=\"red\">-7.8%</font>) falls hard after providing mixed guidance with its <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/1015621\">Q1 beat</a>. The online marketing software firm (to a large extent e-mail-focused) expects Q2 revenue of $91M-$92M and EPS of -$0.10 to -$0.12 vs. a consensus of $91.9M and -$0.08. 2013 guidance is for revenue of $376M-$379M and EPS of -$0.29 to -$0.31 vs. a consensus of $374.4M and -$0.30. Spending remains aggressive: sales/marketing spend +52% Y/Y in Q1 (above rev. growth of 39%) and 43% of revenue. On the <a target=\"_blank\" href=\"https://seekingalpha.com/article/1422521-exacttarget-management-discusses-q1-2013-results-earnings-call-transcript\">earnings call</a>, CEO Scott Dorsey stated headcount rose by 108 Q/Q to 1,781, and is expected to keep rising by ~100/quarter going forward.<div class=\"tiny-share-widget\" data-id=\"1019261\" data-linked=\"Perpetually range-bound ExactTarget (ET-OLD -7.8%) falls hard after providing mixed guidance...\" data-tweet=\"$ET-OLD - Perpetually range-bound ExactTarget (ET-OLD -7.8%) falls hard after providing mixed guidance with its Q1 beat. The online marketing software firm (to a large extent e-mail-focused) expects Q2 revenue of $91M-$92M and EPS of -$0.10 to -$0.12 vs... https://seekingalpha.com/news/1019261?source=tweet\" data-url=\"https://seekingalpha.com/news/1019261\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:43 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1019251\" data-ts=\"1368211163\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AGNC\" target=\"_blank\">AGNC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1019251\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gary Kain-led American Capital Agency (AGNC -2.8%) and American Capital Mortgage (MTGE -2%) lead...</a></h4><p>Gary Kain-led American Capital Agency (<a href=\"https://seekingalpha.com/symbol/AGNC\" title=\"AGNC Investment Corp.\">AGNC</a> <font color=\"red\">-2.8%</font>) and American Capital Mortgage (<a href=\"https://seekingalpha.com/symbol/MTGE\" title=\"MTGE Investment Corp.\">MTGE</a> <font color=\"red\">-2%</font>) lead the decline in an all-red mREIT sector (<a href=\"https://seekingalpha.com/symbol/MORT\" title=\"VanEck Vectors Mortgage REIT Income ETF\">MORT</a> <font color=\"red\">-1%</font>) today, with AGNC taking out its post-earnings low from last week. On the <a href=\"https://seekingalpha.com/currents/post/997891\" target=\"_blank\">earnings call</a>, Kain said upward pressure on rates had cooled to start Q2 and book value was headed higher, but markets may not be cooperating. The 10-year yield is up 8 bps today to a near 2-month high. Others: Annaly (<a href=\"https://seekingalpha.com/symbol/NLY\" title=\"Annaly Capital Management, Inc.\">NLY</a> <font color=\"red\">-1.2%</font>), Invesco (<a href=\"https://seekingalpha.com/symbol/IVR\" title=\"Invesco Mortgage Capital Inc.\">IVR</a> <font color=\"red\">-1.2%</font>), MFA (<a href=\"https://seekingalpha.com/symbol/MFA\" title=\"MFA Financial, Inc.\">MFA</a> <font color=\"red\">-1.8%</font>), Western Asset (<a href=\"https://seekingalpha.com/symbol/WMC\" title=\"Western Asset Mortgage Capital Corporation\">WMC</a> <font color=\"red\">-1.3%</font>).</p><div class=\"tiny-share-widget\" data-id=\"1019251\" data-linked=\"Gary Kain-led American Capital Agency (AGNC -2.8%) and American Capital Mortgage (MTGE -2%) lead...\" data-tweet=\"$AGNC $AGNC $MTGE - Gary Kain-led American Capital Agency (AGNC -2.8%) and American Capital Mortgage (MTGE -2%) lead the decline in an all-red mREIT sector (MORT -1%) today, with AGNC taking out its post-earnings low from last week. On the earnings call... https://seekingalpha.com/news/1019251?source=tweet\" data-url=\"https://seekingalpha.com/news/1019251\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1019241\" data-ts=\"1368210695\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MCPIQ\" target=\"_blank\">MCPIQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1019241\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Molycorp (MCP +35.5%) shares are at the day&#39;s high after better-than-expected Q1 results, but at...</a></h4><p>Molycorp (MCP <font color=\"green\">+35.5%</font>) shares are at the day's high after better-than-expected <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/1015981\">Q1 results</a>, but at least some analysts remain cautious. Stifel Nicolaus <a target=\"_blank\" href=\"http://finance.yahoo.com/news/molycorp-shares-strong-1q-163530737.html\">cuts its 2013 earnings forecast</a> on an assumed sales volume decline in part of MCP's business and more conservative pricing. Goldman Sachs shares <a target=\"_blank\" href=\"http://www.streetinsider.com/Analyst+Comments/Molycorp+%28MCP%29+Demand+Improves+but+Co.+Not+Out+of+Woods+on+Pricing/8326153.html\">concerns about pricing</a> until the integration of its <a href=\"https://seekingalpha.com/currents/post/1018531\" target=\"_blank\">chlor-alkali plant</a> later this year.</p><div class=\"tiny-share-widget\" data-id=\"1019241\" data-linked=\"Molycorp (MCP +35.5%) shares are at the day&#39;s high after better-than-expected Q1 results, but at...\" data-tweet=\"$MCPIQ - Molycorp (MCP +35.5%) shares are at the day&#39;s high after better-than-expected Q1 results, but at least some analysts remain cautious. Stifel Nicolaus cuts its 2013 earnings forecast on an assumed sales volume decline in part of MCP&#39;s business a... https://seekingalpha.com/news/1019241?source=tweet\" data-url=\"https://seekingalpha.com/news/1019241\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1019221\" data-ts=\"1368210088\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BKNG\" target=\"_blank\">BKNG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1019221\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">&quot;Priceline (PCLN +3.8%) is benefiting from stability in its core European market and continues...</a></h4><p>\"Priceline (PCLN <font color=\"green\">+3.8%</font>) is benefiting from stability in its core European market and continues to gain share in global hotel bookings,\" <a href=\"http://www.streetinsider.com/Analyst+Comments/Priceline.com+%28PCLN%29+Q1+Solid+-+Analyst/8326303.html\" target=\"_blank\">writes Cantor</a>, providing an upbeat take on the Q1 report that's echoed by many on the sell-side. Though not pleased with Priceline's <a href=\"https://seekingalpha.com/currents/post/1015711\" target=\"_blank\">light Q2 guidance</a>, the firm sees it as understandable in light of macro, an early Easter, and ad spending needs. But <a href=\"http://www.streetinsider.com/Analyst+Comments/Deutsche+Bank+Lowers+Target+on+priceline.com+%28PCLN%29+to+%24715%2C+Worries+Over+Margin+Compression/8326478.html\" target=\"_blank\">Deutsche</a> is worried margins are at risk thanks to ad spend, and a mix shift to lower-margin regions and paid channels (i.e. Google). Though Priceline is rallying, Expedia (<a href=\"https://seekingalpha.com/symbol/EXPE\" title=\"Expedia, Inc.\">EXPE</a> <font color=\"green\">+5.3%</font>) and Travelzoo (<a href=\"https://seekingalpha.com/symbol/TZOO\" title=\"Travelzoo Inc\">TZOO</a> <font color=\"green\">+6.6%</font>) are faring even better. (<a href=\"https://seekingalpha.com/article/1421911-priceline-com-s-ceo-discusses-q1-2013-results-earnings-call-transcript\" target=\"_blank\">transcript</a>) (<a href=\"https://seekingalpha.com/currents/search?query=pcln\" target=\"_blank\">previous</a>)</p><div class=\"tiny-share-widget\" data-id=\"1019221\" data-linked=\"&quot;Priceline (PCLN +3.8%) is benefiting from stability in its core European market and continues...\" data-tweet=\"$BKNG $BKNG $EXPE - &quot;Priceline (PCLN +3.8%) is benefiting from stability in its core European market and continues to gain share in global hotel bookings,&quot; writes Cantor, providing an upbeat take on the Q1 report that&#39;s echoed by many on the sell-side. ... https://seekingalpha.com/news/1019221?source=tweet\" data-url=\"https://seekingalpha.com/news/1019221\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:21 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1019201\" data-ts=\"1368208943\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HUSA\" target=\"_blank\">HUSA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1019201\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Houston American Energy (HUSA +24%) soars after announcing recompletion and initial test results...</a></h4><p>Houston American Energy (<a href=\"https://seekingalpha.com/symbol/HUSA\" title=\"Houston American Energy Corp.\">HUSA</a> <font color=\"green\">+24%</font>) soars after announcing recompletion and initial test results from the Crown Paper #1 well in Louisiana. HUSA holds a 5.675% royalty interest in the well, which will be reduced to a 2.838% royalty interest after it receives $225K in payments.</p><div class=\"tiny-share-widget\" data-id=\"1019201\" data-linked=\"Houston American Energy (HUSA +24%) soars after announcing recompletion and initial test results...\" data-tweet=\"$HUSA - Houston American Energy (HUSA +24%) soars after announcing recompletion and initial test results from the Crown Paper #1 well in Louisiana. HUSA holds a 5.675% royalty interest in the well, which will be reduced to a 2.838% royalty interest afte... https://seekingalpha.com/news/1019201?source=tweet\" data-url=\"https://seekingalpha.com/news/1019201\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1019181\" data-ts=\"1368208828\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHE\" target=\"_blank\">CHE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1019181\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chemed (CHE -5.3%) takes a hit from a negative Citron Research report calling it &#39;Game Over&#39; for...</a></h4>Chemed (<a href='https://seekingalpha.com/symbol/CHE' title='Chemed Corporation'>CHE</a> <font color=\"red\">-5.3%</font>) takes a hit from a negative <a href=\"http://www.citronresearch.com/wp-content/uploads/2013/05/Chemed-Game-Over-final.pdf\" target=\"_blank\">Citron Research report</a> calling it 'Game Over' for the shares. Citron says that the recent <a href=\"https://seekingalpha.com/market_currents/post/997391\" target=\"_blank\">False Claims suit</a> filed against the company's VITAS business units is just the tip of the spear. Not only has the analyst community overlooked a second, equally damaging suit that was filed, but the government's takeover of the investigation means a potential trebling of damages against the company.<div class=\"tiny-share-widget\" data-id=\"1019181\" data-linked=\"Chemed (CHE -5.3%) takes a hit from a negative Citron Research report calling it &#39;Game Over&#39; for...\" data-tweet=\"$CHE - Chemed (CHE -5.3%) takes a hit from a negative Citron Research report calling it &#39;Game Over&#39; for the shares. Citron says that the recent False Claims suit filed against the company&#39;s VITAS business units is just the tip of the spear. Not only has... https://seekingalpha.com/news/1019181?source=tweet\" data-url=\"https://seekingalpha.com/news/1019181\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1019171\" data-ts=\"1368208147\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VNDA\" target=\"_blank\">VNDA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1019171\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vanda Pharmaceuticals (VNDA +1%) moves up after Jefferies raises its price target from $6 to $7,...</a></h4><p>Vanda Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/VNDA\" title=\"Vanda Pharmaceuticals Inc.\">VNDA</a> <font color=\"green\">+1%</font>) moves up after Jefferies <a href=\"http://www.streetinsider.com/Analyst+Comments/Jefferies+Lifts+PT+on+Vanda+Pharmaceuticals+%28VNDA%29+to+%247/8327168.html\" target=\"_blank\">raises its price target</a> from $6 to $7, saying that a Tasimelteon filing is forthcoming. The firm notes that <a href=\"https://seekingalpha.com/symbol/VNDA\" title=\"Vanda Pharmaceuticals Inc.\">VNDA</a> has plenty of cash to make it through potential Tasi approval, and it continues to develop market awareness and build pre-launch demand critical mass.</p><div class=\"tiny-share-widget\" data-id=\"1019171\" data-linked=\"Vanda Pharmaceuticals (VNDA +1%) moves up after Jefferies raises its price target from $6 to $7,...\" data-tweet=\"$VNDA - Vanda Pharmaceuticals (VNDA +1%) moves up after Jefferies raises its price target from $6 to $7, saying that a Tasimelteon filing is forthcoming. The firm notes that VNDA has plenty of cash to make it through potential Tasi approval, and it cont... https://seekingalpha.com/news/1019171?source=tweet\" data-url=\"https://seekingalpha.com/news/1019171\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:49 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1019161\" data-ts=\"1368207827\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IVAN\" target=\"_blank\">IVAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1019161\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ivanhoe Energy (IVAN -3.8%) slams allegations in a lawsuit launched against it over an oilfield...</a></h4><p>Ivanhoe Energy (<a href=\"https://seekingalpha.com/symbol/IVAN\" title=\"Ivanhoe Energy, Inc.\">IVAN</a> <font color=\"red\">-3.8%</font>) slams allegations in a lawsuit launched against it over an oilfield development contract in Ecuador, and says the suit will not derail its plans in the country. The action relates to IVAN\u2019s development of the Pungarayacu oilfield; a similar suit was thrown out in a Colorado court in 2009.</p><div class=\"tiny-share-widget\" data-id=\"1019161\" data-linked=\"Ivanhoe Energy (IVAN -3.8%) slams allegations in a lawsuit launched against it over an oilfield...\" data-tweet=\"$IVAN - Ivanhoe Energy (IVAN -3.8%) slams allegations in a lawsuit launched against it over an oilfield development contract in Ecuador, and says the suit will not derail its plans in the country. The action relates to IVAN\u2019s development of the Pungaray... https://seekingalpha.com/news/1019161?source=tweet\" data-url=\"https://seekingalpha.com/news/1019161\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:43 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1019151\" data-ts=\"1368207771\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BT\" target=\"_blank\">BT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1019151\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BT (BT +11.8%) soars after delivering a better-than-expected FQ4 report, hiking its full-year...</a></h4><p>BT (<a href=\"https://seekingalpha.com/symbol/BT\" title=\"BT Group plc\">BT</a> <font color=\"green\">+11.8%</font>) soars after delivering a better-than-expected <a href=\"https://seekingalpha.com/currents/post/1017861\" target=\"_blank\">FQ4 report</a>, hiking its full-year dividend by 14% to £0.095/share ($0.145/share, 3.3% yield), and announcing a £300M/year buyback plan for FY14 and FY15. BT expects FY14 normalized free cash flow to be even with FY13's £2.3B ($3.5B), and see it rising in FY15 to £2.6B ($3.9B). Capex in FY14 and FY15 is expected to be \"broadly level\" with FY13. BT's fiber subscriber base more than doubled in FY13 to 1.5M. But slumping wireline demand and lower mobile termination rates are taking a toll: Global Services revenue -3% Y/Y in FQ4, Retail flat, Wholesale -5%, Openreach (wireline infrastructure) -5%. (PR)</p><div class=\"tiny-share-widget\" data-id=\"1019151\" data-linked=\"BT (BT +11.8%) soars after delivering a better-than-expected FQ4 report, hiking its full-year...\" data-tweet=\"$BT - BT (BT +11.8%) soars after delivering a better-than-expected FQ4 report, hiking its full-year dividend by 14% to £0.095/share ($0.145/share, 3.3% yield), and announcing a £300M/year buyback plan for FY14 and FY15. BT expects FY14 normalized free c... https://seekingalpha.com/news/1019151?source=tweet\" data-url=\"https://seekingalpha.com/news/1019151\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:42 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1019131\" data-ts=\"1368207122\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OPTR\" target=\"_blank\">OPTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1019131\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">The sell-off in Optimer Pharmaceuticals (OPTR -16.6%) accelerates as the session drags on, with...</a></h4><p>The sell-off in Optimer Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/OPTR\" title=\"Optimer Pharmaceuticals, Inc.\">OPTR</a> <font color=\"red\">-16.6%</font>) accelerates as the session drags on, with losses now well into the double-digits. On top of <a href=\"https://seekingalpha.com/currents/post/1018421\" target=\"_blank\">Needham's downgrade</a> (disappointing Dificid sales may equate to less value for anyone planning an acquisition), Baird chimes in as well, <a href=\"http://www.streetinsider.com/Downgrades/Baird+Downgrades+Optimer+Pharmaceuticals+%28OPTR%29+to+Neutral/8325702.html\" target=\"_blank\">cutting the shares to Neutral</a> from Outperform (price target still $16). (<a href=\"https://seekingalpha.com/currents/post/1015511\" target=\"_blank\">earnings</a>, <a href=\"https://seekingalpha.com/article/1422191-optimer-pharmaceuticals-management-discusses-q1-2013-results-earnings-call-transcript\" target=\"_blank\">CC</a>)</p><div class=\"tiny-share-widget\" data-id=\"1019131\" data-linked=\"The sell-off in Optimer Pharmaceuticals (OPTR -16.6%) accelerates as the session drags on, with...\" data-tweet=\"$OPTR - The sell-off in Optimer Pharmaceuticals (OPTR -16.6%) accelerates as the session drags on, with losses now well into the double-digits. On top of Needham&#39;s downgrade (disappointing Dificid sales may equate to less value for anyone planning an ac... https://seekingalpha.com/news/1019131?source=tweet\" data-url=\"https://seekingalpha.com/news/1019131\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:32 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1019121\" data-ts=\"1368206968\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HES\" target=\"_blank\">HES</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1019121\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hess&#39; (HES -2%) about-face in splitting the chairman and CEO roles throws a bone to activist...</a></h4><p>Hess' (<a href=\"https://seekingalpha.com/symbol/HES\" title=\"Hess Corporation\">HES</a> <font color=\"red\">-2%</font>) about-face in <a href=\"https://seekingalpha.com/currents/post/1017481\" target=\"_blank\">splitting the chairman and CEO roles</a> throws a bone to activist investors staging a proxy fight, but Elliott Management <a href=\"http://www.forbes.com/sites/steveschaefer/2013/05/10/hess-throws-a-bone-with-chairman-ceo-split-before-proxy-vote-but-elliott-isnt-biting\" target=\"_blank\">isn't biting</a>, calling it \u201ca reaction to the shareholder vote currently underway.\u201d The suddenness of the move sends a signal there's <a href=\"http://online.wsj.com/article/SB10001424127887324059704578475000723535388.html\" target=\"_blank\">blood in the water</a> ahead of next Thursday's shareholder meeting, <em>WSJ</em>'s Liam Denning writes.</p><div class=\"tiny-share-widget\" data-id=\"1019121\" data-linked=\"Hess&#39; (HES -2%) about-face in splitting the chairman and CEO roles throws a bone to activist...\" data-tweet=\"$HES - Hess&#39; (HES -2%) about-face in splitting the chairman and CEO roles throws a bone to activist investors staging a proxy fight, but Elliott Management isn&#39;t biting, calling it \u201ca reaction to the shareholder vote currently underway.\u201d The suddenness ... https://seekingalpha.com/news/1019121?source=tweet\" data-url=\"https://seekingalpha.com/news/1019121\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:29 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1019111\" data-ts=\"1368206813\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAT\" target=\"_blank\">CAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1019111\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Caterpillar (CAT -1.7%) and the United Steelworkers Union have suspended contract negotiations...</a></h4><p>Caterpillar (<a href=\"https://seekingalpha.com/symbol/CAT\" title=\"Caterpillar Inc.\">CAT</a> <font color=\"red\">-1.7%</font>) and the United Steelworkers Union have <a href=\"http://www.chicagotribune.com/business/breaking/chi-caterpillar-union-suspend-talks-in-milwaukee-20130510,0,6526652.story\" target=\"_blank\">suspended contract negotiations</a> for mining machinery workers in Milwaukee after talks broke down earlier this week. The union rejected a proposed contract that would have frozen hourly wages for six years, installed a lower wage scale for new hires, altered pension benefits and allowed the company to disregard workers' seniority when selecting employees for short-term layoffs. Workers say they will continue to report and presently have no plans to stage a walkout.</p><div class=\"tiny-share-widget\" data-id=\"1019111\" data-linked=\"Caterpillar (CAT -1.7%) and the United Steelworkers Union have suspended contract negotiations...\" data-tweet=\"$CAT - Caterpillar (CAT -1.7%) and the United Steelworkers Union have suspended contract negotiations for mining machinery workers in Milwaukee after talks broke down earlier this week. The union rejected a proposed contract that would have frozen hourl... https://seekingalpha.com/news/1019111?source=tweet\" data-url=\"https://seekingalpha.com/news/1019111\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1019041\" data-ts=\"1368205363\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALBO\" target=\"_blank\">ALBO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1019041\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Biodel (BIOD +2.2%) rises on an upgrade to Buy from Neutral at Ladenburg Thalmann (price target...</a></h4><p>Biodel (BIOD <font color=\"green\">+2.2%</font>) rises on an <a href=\"http://www.streetinsider.com/Upgrades/Ladenburg+Thalmann+Upgrades+Biodel+%28BIOD%29+to+Buy/8326951.html\" target=\"_blank\">upgrade to Buy</a> from Neutral at Ladenburg Thalmann (price target $6). The stock has trended higher this month as the company readies top line results (due Q3) for a Phase 2 trial of BIOD-123, one of a few candidates investors hope will help spark a resurgence for the company after the disappointing rejection of Linjeta in November of 2010. (<a href=\"https://seekingalpha.com/currents/post/1008911\" target=\"_blank\">earnings</a>, <a href=\"https://seekingalpha.com/article/1414921-biodel-s-ceo-discusses-f2q13-results-earnings-call-transcript\" target=\"_blank\">CC</a>)</p><div class=\"tiny-share-widget\" data-id=\"1019041\" data-linked=\"Biodel (BIOD +2.2%) rises on an upgrade to Buy from Neutral at Ladenburg Thalmann (price target...\" data-tweet=\"$ALBO - Biodel (BIOD +2.2%) rises on an upgrade to Buy from Neutral at Ladenburg Thalmann (price target $6). The stock has trended higher this month as the company readies top line results (due Q3) for a Phase 2 trial of BIOD-123, one of a few candidate... https://seekingalpha.com/news/1019041?source=tweet\" data-url=\"https://seekingalpha.com/news/1019041\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1019001\" data-ts=\"1368204740\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UNIS\" target=\"_blank\">UNIS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1019001\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday top 10 gainers: UNIS +58%. DRAM +57%. VRML +26%. SREV +22%. MCP +20%. UBNT +18%. RH +18%....</a></h4><b>Midday top 10 gainers:</b> <a href='https://seekingalpha.com/symbol/UNIS' title='Unilife Corporation'>UNIS</a> <font color=\"green\">+58%</font>. DRAM <font color=\"green\">+57%</font>. <a href='https://seekingalpha.com/symbol/VRML' title='Vermillion, Inc.'>VRML</a> <font color=\"green\">+26%</font>. <a href='https://seekingalpha.com/symbol/SREV' title='ServiceSource International, Inc.'>SREV</a> <font color=\"green\">+22%</font>. MCP <font color=\"green\">+20%</font>. <a href='https://seekingalpha.com/symbol/UBNT' title='Ubiquiti Networks, Inc.'>UBNT</a> <font color=\"green\">+18%</font>. <a href='https://seekingalpha.com/symbol/RH' title='RH'>RH</a> <font color=\"green\">+18%</font>. <a href='https://seekingalpha.com/symbol/WCRX' title='Warner Chilcott Limited'>WCRX</a> <font color=\"green\">+17%</font>. <a href='https://seekingalpha.com/symbol/CSIQ' title='Canadian Solar Inc.'>CSIQ</a> <font color=\"green\">+16%</font>. <a href='https://seekingalpha.com/symbol/SQNM' title='Sequenom, Inc.'>SQNM</a> <font color=\"green\">+16%</font>.<br /> <b>Midday top 10 losers:</b> <a href='https://seekingalpha.com/symbol/PTIE' title='Pain Therapeutics'>PTIE</a> <font color=\"red\">-48%</font>. <a href='https://seekingalpha.com/symbol/DRRX' title='Durect Corporation'>DRRX</a> <font color=\"red\">-41%</font>. IFMI <font color=\"red\">-34%</font>. <a href='https://seekingalpha.com/symbol/AFFY' title='Affymax, Inc.'>OTC:AFFY</a> <font color=\"red\">-26%</font>. <a href='https://seekingalpha.com/symbol/SRT' title='StarTek, Inc.'>SRT</a> <font color=\"red\">-23%</font>. <a href='https://seekingalpha.com/symbol/LPDX' title='LipoScience'>LPDX</a> <font color=\"red\">-22%</font>. <a href='https://seekingalpha.com/symbol/OPTR' title='Optimer Pharmaceuticals, Inc.'>OPTR</a> <font color=\"red\">-17%</font>. <a href='https://seekingalpha.com/symbol/REFR' title='Research Frontiers Incorporated'>REFR</a> <font color=\"red\">-16%</font>. <a href='https://seekingalpha.com/symbol/PANL' title='Pangaea Logistics Solutions Ltd.'>PANL</a> <font color=\"red\">-16%</font>. <a href='https://seekingalpha.com/symbol/TRMD-OLD' title='Steamship Co. Torm A/S'>TRMD-OLD</a> <font color=\"red\">-15%</font>.<div class=\"tiny-share-widget\" data-id=\"1019001\" data-linked=\"Midday top 10 gainers: UNIS +58%. DRAM +57%. VRML +26%. SREV +22%. MCP +20%. UBNT +18%. RH +18%....\" data-tweet=\"$UNIS $UNIS $USAU - Midday top 10 gainers: UNIS +58%. DRAM +57%. VRML +26%. SREV +22%. MCP +20%. UBNT +18%. RH +18%. WCRX +17%. CSIQ +16%. SQNM +16%. Midday top 10 losers: PTIE -48%. DRRX -41%. IFMI -34%. OTC:AFFY -26%. SRT -23%. LPDX -22%. OPTR -17%. R... https://seekingalpha.com/news/1019001?source=tweet\" data-url=\"https://seekingalpha.com/news/1019001\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:52 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1018981\" data-ts=\"1368204503\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GEVA\" target=\"_blank\">GEVA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1018981\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Synageva BioPharma (GEVA -5.5%) slips today after JP Morgan cut the shares to Neutral and lowers...</a></h4><p>Synageva BioPharma (<a href=\"https://seekingalpha.com/symbol/GEVA\" title=\"Synageva BioPharma Corp.\">GEVA</a> <font color=\"red\">-5.5%</font>) slips today after JP Morgan <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/13/05/3579494/update-j-p-morgan-downgrades-synageva-biopharma-to-neutr#\" target=\"_blank\">cut the shares</a> to Neutral and lowers its price target from $57 to $50. The firm cites concerns over enrollment challenges related to its ongoing Phase 3 trial of sebelipase alfa in late-onset LAL Deficiency, saying that awareness of the disease is fairly low, even among specialists, so patient identification could take a bit longer.</p><div class=\"tiny-share-widget\" data-id=\"1018981\" data-linked=\"Synageva BioPharma (GEVA -5.5%) slips today after JP Morgan cut the shares to Neutral and lowers...\" data-tweet=\"$GEVA - Synageva BioPharma (GEVA -5.5%) slips today after JP Morgan cut the shares to Neutral and lowers its price target from $57 to $50. The firm cites concerns over enrollment challenges related to its ongoing Phase 3 trial of sebelipase alfa in late... https://seekingalpha.com/news/1018981?source=tweet\" data-url=\"https://seekingalpha.com/news/1018981\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:48 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1018961\" data-ts=\"1368204041\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AGN\" target=\"_blank\">AGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1018961\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Actavis (ACT +6.1%) / Warner Chilcott (WCRX +12.3%): The news comes just weeks after ACT...</a></h4><p>More on Actavis (<a href=\"https://seekingalpha.com/symbol/ACT\" title=\"AdvisorShares Vice ETF\">ACT</a> <font color=\"green\">+6.1%</font>) / Warner Chilcott (<a href=\"https://seekingalpha.com/symbol/WCRX\" title=\"Warner Chilcott Limited\">WCRX</a> <font color=\"green\">+12.3%</font>): The news comes just weeks after <a href=\"https://seekingalpha.com/symbol/ACT\" title=\"AdvisorShares Vice ETF\">ACT</a> <a href=\"https://seekingalpha.com/market_currents/post/976251\" target=\"_blank\">broke off merger talks</a> with Valeant Pharmaceuticals (VRX <font color=\"green\">+0.5%</font>) after balking at the premium it was offered. Now, considering the strength of <a href=\"https://seekingalpha.com/symbol/ACT\" title=\"AdvisorShares Vice ETF\">ACT</a>'s recent <a href=\"https://seekingalpha.com/market_currents/post/990631\" target=\"_blank\">Q1 report</a>, that deal looks dead. Warner, on the other hand, had disclosed over a year ago that it was <a href=\"http://dealbook.nytimes.com/2012/04/30/warner-chilcott-says-it-is-in-preliminary-sale-talks/\" target=\"_blank\">pursuing a sale</a>.</p><div class=\"tiny-share-widget\" data-id=\"1018961\" data-linked=\"More on Actavis (ACT +6.1%) / Warner Chilcott (WCRX +12.3%): The news comes just weeks after ACT...\" data-tweet=\"$AGN $AGN $WCRX - More on Actavis (ACT +6.1%) / Warner Chilcott (WCRX +12.3%): The news comes just weeks after ACT broke off merger talks with Valeant Pharmaceuticals (VRX +0.5%) after balking at the premium it was offered. Now, considering the strength... https://seekingalpha.com/news/1018961?source=tweet\" data-url=\"https://seekingalpha.com/news/1018961\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:40 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1018951\" data-ts=\"1368203649\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LPDX\" target=\"_blank\">LPDX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1018951\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">LipoScience (LPDX -22.8%) tanks after CEO Richard Brajer expresses his dissatisfaction with the...</a></h4><p>LipoScience (<a href=\"https://seekingalpha.com/symbol/LPDX\" title=\"LipoScience\">LPDX</a> <font color=\"red\">-22.8%</font>) tanks after CEO Richard Brajer expresses his dissatisfaction with the company's <a href=\"https://seekingalpha.com/currents/post/1017001\" target=\"_blank\">revenue performance in Q1</a> (<font color=\"red\">-1.2%</font> Y/Y). LipoProfile test order growth fell to 8.7% Y/Y versus Y/Y growth of 14.8% in Q4, although orders did rise Q/Q. The main problems \u2014 which include difficulties ramping up new sales reps, faster direct business-to-lab partner conversion, and managed care headwinds \u2014 \"cannot be fixed overnight,\" Brajer laments. In light of this, LPDX lowers its FY13 revenue guidance to $54-56M (consensus is $61.43M). (PR)</p><div class=\"tiny-share-widget\" data-id=\"1018951\" data-linked=\"LipoScience (LPDX -22.8%) tanks after CEO Richard Brajer expresses his dissatisfaction with the...\" data-tweet=\"$LPDX - LipoScience (LPDX -22.8%) tanks after CEO Richard Brajer expresses his dissatisfaction with the company&#39;s revenue performance in Q1 (-1.2% Y/Y). LipoProfile test order growth fell to 8.7% Y/Y versus Y/Y growth of 14.8% in Q4, although orders did... https://seekingalpha.com/news/1018951?source=tweet\" data-url=\"https://seekingalpha.com/news/1018951\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:34 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1018941\" data-ts=\"1368203576\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KATE\" target=\"_blank\">KATE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1018941\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">A number of retailers are seeing some speculative buying after True Religion TRLG lands a...</a></h4>A number of retailers are seeing some speculative buying after True Religion TRLG <a href=\"https://seekingalpha.com/currents/post/1018441\" target=\"_blank\">lands</a> a takeover offer and Gap puts in a powerhouse month for sales to help lift sentiment. The S&amp;P Retail ETF (NYSEARCA:<a href='https://seekingalpha.com/symbol/XRT' title='SPDR S&P Retail ETF'>XRT</a>) is <font color=\"green\">up 1.1%</font>, but might be doing better on the day if not for its heavy weighting currently into drugstore and grocery stocks. Gainers: FNP <font color=\"green\">+4.1%</font>, <a href='https://seekingalpha.com/symbol/JOEZ' title='Joe&#39;s Jeans Inc.'>JOEZ</a> <font color=\"green\">+2.3%</font>, <a href='https://seekingalpha.com/symbol/VFC' title='V.F. Corporation'>VFC</a> <font color=\"green\">+1.5%</font>, <a href='https://seekingalpha.com/symbol/JNY' title='The Jones Group Inc.'>JNY</a> <font color=\"green\">+1.9%</font>, <a href='https://seekingalpha.com/symbol/GES' title='Guess? Inc.'>GES</a> <font color=\"green\">+2.1%</font>, APP <font color=\"green\">+2.2%</font>, <a href='https://seekingalpha.com/symbol/BKE' title='The Buckle, Inc.'>BKE</a> <font color=\"green\">+1.5%</font>.<div class=\"tiny-share-widget\" data-id=\"1018941\" data-linked=\"A number of retailers are seeing some speculative buying after True Religion TRLG lands a...\" data-tweet=\"$KATE $XRT $KATE - A number of retailers are seeing some speculative buying after True Religion TRLG lands a takeover offer and Gap puts in a powerhouse month for sales to help lift sentiment. The S&amp;P Retail ETF (NYSEARCA:XRT) is up 1.1%, but might be d... https://seekingalpha.com/news/1018941?source=tweet\" data-url=\"https://seekingalpha.com/news/1018941\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1018931\" data-ts=\"1368203429\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MPC\" target=\"_blank\">MPC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1018931\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">At least 230 barrels of diesel fuel have leaked from a Marathon Petroleum (MPC -2.3%) pipeline...</a></h4><p>At least 230 barrels of diesel fuel have <a href=\"http://online.wsj.com/article/SB10001424127887323744604578474873710083886.html\" target=\"_blank\">leaked</a> from a Marathon Petroleum (<a href=\"https://seekingalpha.com/symbol/MPC\" title=\"Marathon Petroleum Corp.\">MPC</a> <font color=\"red\">-2.3%</font>) pipeline in an industrial area of Indianapolis. MPC says the pipeline wasn't flowing at the time of the leak because of a lull in market demand, but it was pressurized with diesel in it. The leak is believed to have occurred slowly over time, not the result of a sudden break or external forces.</p><div class=\"tiny-share-widget\" data-id=\"1018931\" data-linked=\"At least 230 barrels of diesel fuel have leaked from a Marathon Petroleum (MPC -2.3%) pipeline...\" data-tweet=\"$MPC - At least 230 barrels of diesel fuel have leaked from a Marathon Petroleum (MPC -2.3%) pipeline in an industrial area of Indianapolis. MPC says the pipeline wasn&#39;t flowing at the time of the leak because of a lull in market demand, but it was pres... https://seekingalpha.com/news/1018931?source=tweet\" data-url=\"https://seekingalpha.com/news/1018931\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:30 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1018921\" data-ts=\"1368203357\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSL\" target=\"_blank\">TSL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1018921\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Volatile/well-shorted solar stocks are ripping higher (TAN +5.4%) to close out a week in which...</a></h4><p>Volatile/well-shorted solar stocks are ripping higher (<a href=\"https://seekingalpha.com/symbol/TAN\" title=\"Invesco Solar Portfolio ETF\">TAN</a> <font color=\"green\">+5.4%</font>) to close out a week in which <a target=\"_blank\" href=\"http://www.reuters.com/article/2013/05/08/eu-china-solar-idUSL6N0DP29X20130508\">the EU imposed</a> long-expected tariffs on Chinese solar panel imports. <a href=\"https://seekingalpha.com/symbol/TSL\" title=\"Trina Solar Limited\">TSL</a> <font color=\"green\">+10%</font>. <a href=\"https://seekingalpha.com/symbol/CSIQ\" title=\"Canadian Solar Inc.\">CSIQ</a> <font color=\"green\">+16.1%</font>. <a href=\"https://seekingalpha.com/symbol/STP\" title=\"Suntech Power Holdings Co., Ltd.\">STP</a> <font color=\"green\">+9.1%</font>. SCTY <font color=\"green\">+8.6%</font>. <a href=\"https://seekingalpha.com/symbol/SOL\" title=\"ReneSola Ltd.\">SOL</a> <font color=\"green\">+8.3%</font>. <a href=\"https://seekingalpha.com/symbol/JASO\" title=\"JA Solar Holdings, Co., Ltd.\">JASO</a> <font color=\"green\">+7.5%</font>. <a href=\"https://seekingalpha.com/symbol/FSLR\" title=\"First Solar, Inc.\">FSLR</a> <font color=\"green\">+4.6%</font>. <a href=\"https://seekingalpha.com/symbol/JKS\" title=\"JinkoSolar Holding Co., Ltd.\">JKS</a> <font color=\"green\">+9.4%</font>. <a href=\"https://seekingalpha.com/symbol/LDK\" title=\"LDK Solar Co., Ltd.\">LDK</a> <font color=\"green\">+3.4%</font>. <a href=\"https://seekingalpha.com/symbol/SPWR\" title=\"SunPower Corporation\">SPWR</a> <font color=\"green\">+7.8%</font> A <a target=\"_blank\" href=\"http://www.reuters.com/article/2013/05/10/column-wynn-solar-prices-idUSL6N0DR10G20130510?feedType=RSS&amp;feedName=industrialsSector&amp;rpc=43\">Reuters column</a> today notes the pace of module price declines is expected to slow, as weaker players are <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/888611\">forced out</a> and U.S./emerging markets <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/888671\">demand</a> gradually soaks up excess capacity.</p><div class=\"tiny-share-widget\" data-id=\"1018921\" data-linked=\"Volatile/well-shorted solar stocks are ripping higher (TAN +5.4%) to close out a week in which...\" data-tweet=\"$TSL $TAN $TSL - Volatile/well-shorted solar stocks are ripping higher (TAN +5.4%) to close out a week in which the EU imposed long-expected tariffs on Chinese solar panel imports. TSL +10%. CSIQ +16.1%. STP +9.1%. SCTY +8.6%. SOL +8.3%. JASO +7.5%. FSL... https://seekingalpha.com/news/1018921?source=tweet\" data-url=\"https://seekingalpha.com/news/1018921\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1018911\" data-ts=\"1368203006\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOLD\" target=\"_blank\">GOLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1018911\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">The mini-recovery in gold and metals mining stocks is stopped as gold prices sink 3% today to...</a></h4><p>The mini-recovery in gold and metals mining stocks is <a href=\"http://blogs.barrons.com/stockstowatchtoday/2013/05/10/miners-having-a-down-day-as-gold-prices-fall\" target=\"_blank\">stopped</a> as gold prices sink 3% today to ~$1,425/oz. after closing higher in each of the past two weeks. A breach of key chart levels is <a href=\"http://www.cnbc.com/id/100725915\" target=\"_blank\">prompting heavy selling</a> of gold futures, already under pressure from a <a href=\"https://seekingalpha.com/currents/post/1017581\" target=\"_blank\">stronger dollar</a> and rising stock markets. Among big miners: ABX <font color=\"red\">-3%</font>, <a href=\"https://seekingalpha.com/symbol/NEM\" title=\"Newmont Mining Corporation (Holding Company)\">NEM</a> <font color=\"red\">-2.1%</font>, <a href=\"https://seekingalpha.com/symbol/GG\" title=\"Goldcorp Inc.\">GG</a> <font color=\"red\">-1.6%</font>, <a href=\"https://seekingalpha.com/symbol/KGC\" title=\"Kinross Gold Corporation\">KGC</a> <font color=\"red\">-3.8%</font>, SLW <font color=\"red\">-2.7%</font>, <a href=\"https://seekingalpha.com/symbol/FCX\" title=\"Freeport-McMoRan Inc.\">FCX</a> <font color=\"red\">-1.8%</font>.</p><div class=\"tiny-share-widget\" data-id=\"1018911\" data-linked=\"The mini-recovery in gold and metals mining stocks is stopped as gold prices sink 3% today to...\" data-tweet=\"$GOLD $GOLD $NEM - The mini-recovery in gold and metals mining stocks is stopped as gold prices sink 3% today to ~$1,425/oz. after closing higher in each of the past two weeks. A breach of key chart levels is prompting heavy selling of gold futures, alr... https://seekingalpha.com/news/1018911?source=tweet\" data-url=\"https://seekingalpha.com/news/1018911\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:23 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1018891\" data-ts=\"1368202666\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AGN\" target=\"_blank\">AGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1018891\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Actavis (ACT +3%) spike higher on reports the company is in early-stage talks to...</a></h4>Shares of Actavis (<a href='https://seekingalpha.com/symbol/ACT' title='AdvisorShares Vice ETF'>ACT</a> <font color=\"green\">+3%</font>) spike higher on reports the company is in <a href=\"https://twitter.com/TheDomino/status/332890490431234049\" target=\"_blank\">early-stage talks</a> to acquire Warner Chilcott (<a href='https://seekingalpha.com/symbol/WCRX' title='Warner Chilcott Limited'>WCRX</a> <font color=\"green\">+9.5%</font>).<div class=\"tiny-share-widget\" data-id=\"1018891\" data-linked=\"Shares of Actavis (ACT +3%) spike higher on reports the company is in early-stage talks to...\" data-tweet=\"$AGN $AGN $WCRX - Shares of Actavis (ACT +3%) spike higher on reports the company is in early-stage talks to acquire Warner Chilcott (WCRX +9.5%). https://seekingalpha.com/news/1018891?source=tweet\" data-url=\"https://seekingalpha.com/news/1018891\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:17 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1018881\" data-ts=\"1368202245\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MBI\" target=\"_blank\">MBI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1018881\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">&quot;We expect to be in a position to write business and add to shareholder value in the near...</a></h4>\"We expect to be in a position to write business and add to shareholder value in the near future,\" says MBIA (<a href='https://seekingalpha.com/symbol/MBI' title='MBIA Inc.'>MBI</a> <font color='red'>-3.1%</font>) CFO Chuck Chaplin, talking about National Public Finance on the earnings call (<a href=\"https://seekingalpha.com/article/1423861-mbia-management-discusses-q1-2013-results-earnings-call-transcript?part=single\" target=\"_blank\">transcript</a>). This week's settlements have a \"huge impact\" on National capital adequacy, he says, and the unit's marketing, underwriting, and servicing platforms are ready to begin firing again.<div class=\"tiny-share-widget\" data-id=\"1018881\" data-linked=\"&quot;We expect to be in a position to write business and add to shareholder value in the near...\" data-tweet=\"$MBI - &quot;We expect to be in a position to write business and add to shareholder value in the near future,&quot; says MBIA (MBI -3.1%) CFO Chuck Chaplin, talking about National Public Finance on the earnings call (transcript). This week&#39;s settlements have a &quot;h... https://seekingalpha.com/news/1018881?source=tweet\" data-url=\"https://seekingalpha.com/news/1018881\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:10 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1018871\" data-ts=\"1368202199\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GSK\" target=\"_blank\">GSK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1018871\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GlaxoSmithKline (GSK +1.5%) and Theravance (THRX +11%) both move higher today after the FDA...</a></h4><p>GlaxoSmithKline (<a href=\"https://seekingalpha.com/symbol/GSK\" title=\"GlaxoSmithKline\">GSK</a> <font color=\"green\">+1.5%</font>) and Theravance (THRX <font color=\"green\">+11%</font>) both move higher today after the <a href=\"http://www.nasdaq.com/article/fda-approves-glaxosmithklines-breo-ellipta-to-treat-lung-disease-20130510-00535\" target=\"_blank\">FDA approves</a> Breo Ellipta for the treatment of airflow obstruction in patients with chronic obstructive pulmonary disease, including chronic bronchitis and/or emphysema. The approval was widely expected after a federal advisory panel endorsed the product last month.</p><div class=\"tiny-share-widget\" data-id=\"1018871\" data-linked=\"GlaxoSmithKline (GSK +1.5%) and Theravance (THRX +11%) both move higher today after the FDA...\" data-tweet=\"$GSK $GSK $INVA - GlaxoSmithKline (GSK +1.5%) and Theravance (THRX +11%) both move higher today after the FDA approves Breo Ellipta for the treatment of airflow obstruction in patients with chronic obstructive pulmonary disease, including chronic bronch... https://seekingalpha.com/news/1018871?source=tweet\" data-url=\"https://seekingalpha.com/news/1018871\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:09 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1018861\" data-ts=\"1368202165\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UBNT\" target=\"_blank\">UBNT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1018861\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ubiquiti (UBNT +21.2%) hits levels last seen 12 months ago after beating Q1 estimates and...</a></h4><p>Ubiquiti (<a href=\"https://seekingalpha.com/symbol/UBNT\" title=\"Ubiquiti Networks, Inc.\">UBNT</a> <font color=\"green\">+21.2%</font>) hits levels last seen 12 months ago after <a href=\"https://seekingalpha.com/currents/post/1015611\" target=\"_blank\">beating Q1 estimates </a>and guiding for Q2 revenue of $90M-$96M and EPS of $0.26-$0.29 - that's above a consensus of $86.2M and $0.23. 32% of the float was shorted as of April 30. Raymond James has upgraded shares to Outperform, and <a href=\"http://news.investors.com/technology/051013-655603-ubiquiti-fiscal-q3-revenue-falls-but-beats-expectations.htm\" target=\"_blank\">Pac Crest</a> is \"encouraged by improving visibility and balance-sheet metrics\" following a dismal 2012 featuring <a href=\"https://seekingalpha.com/currents/post/479741\" target=\"_blank\">bad guidance</a>, <a href=\"https://seekingalpha.com/currents/post/380791\" target=\"_blank\">counterfeit product issues</a>, inventory issues, and <a href=\"https://seekingalpha.com/currents/post/445281\" target=\"_blank\">a few other things</a>. On the <a href=\"https://seekingalpha.com/article/1422231-ubiquiti-networks-management-discusses-q3-2013-results-earnings-call-transcript\" target=\"_blank\">earnings call</a>, CEO/Memphis Grizzlies owner Robert Pera mentioned sales of Ubiquiti's <a href=\"http://www.ubnt.com/airmax\" target=\"_blank\">airMAX</a> wireless transmission systems rose 14% Q/Q.</p><div class=\"tiny-share-widget\" data-id=\"1018861\" data-linked=\"Ubiquiti (UBNT +21.2%) hits levels last seen 12 months ago after beating Q1 estimates and...\" data-tweet=\"$UBNT $UI - Ubiquiti (UBNT +21.2%) hits levels last seen 12 months ago after beating Q1 estimates and guiding for Q2 revenue of $90M-$96M and EPS of $0.26-$0.29 - that&#39;s above a consensus of $86.2M and $0.23. 32% of the float was shorted as of April 30.... https://seekingalpha.com/news/1018861?source=tweet\" data-url=\"https://seekingalpha.com/news/1018861\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:09 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1018841\" data-ts=\"1368201278\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NGVC\" target=\"_blank\">NGVC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1018841\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Natural Grocers (NGVC +8.9%) soars after its earnings beat estimates. From the report: Net sales...</a></h4><p>Natural Grocers (<a href=\"https://seekingalpha.com/symbol/NGVC\" title=\"Natural Grocers\">NGVC</a> <font color=\"green\">+8.9%</font>) soars after its earnings beat estimates. From the report: Net sales rise <font color=\"green\">25.4%</font> Y/Y, comparable store sales growth is 10.6%, and EBITDA increases <font color=\"green\">28.3%</font> over Q2 2012. Gross margin fell slightly. The company says it will open 13 new stores in FY13, up from previous guidance of 12. NGVC now targets 8.5-9.5% comps growth for the full year, also higher than previously forecast. The results call to mind Marc Courtenay's April 8 article on TheStreet.com which <a href=\"https://seekingalpha.com/currents/post/931251\" target=\"_blank\">called the company</a> WFM's \"only real competition.\"(PR)</p><div class=\"tiny-share-widget\" data-id=\"1018841\" data-linked=\"Natural Grocers (NGVC +8.9%) soars after its earnings beat estimates. From the report: Net sales...\" data-tweet=\"$NGVC $NGVC $AMZN - Natural Grocers (NGVC +8.9%) soars after its earnings beat estimates. From the report: Net sales rise 25.4% Y/Y, comparable store sales growth is 10.6%, and EBITDA increases 28.3% over Q2 2012. Gross margin fell slightly. The company... https://seekingalpha.com/news/1018841?source=tweet\" data-url=\"https://seekingalpha.com/news/1018841\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:54 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1018801\" data-ts=\"1368200303\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RH\" target=\"_blank\">RH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1018801\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Restoration Hardware (RH +25.5%) leaps higher after &quot;updating&quot; its Q1 outlook. RH now sees...</a></h4><p>Restoration Hardware (<a href=\"https://seekingalpha.com/symbol/RH\" title=\"RH\">RH</a> <font color=\"green\">+25.5%</font>) leaps higher after \"updating\" its Q1 outlook. RH now sees revenues coming in between $295M and $300M (growth of 35-38%) compared to previous guidance of $280-285M (consensus is $284.6M). Additionally, the company says comps will likely grow at a (comically) impressive rate of 41% Y/Y. Furthermore, RH now expects to posted adjusted EPS of $0.02-0.04 against previous guidance of a $0.02 loss. (PR)</p><div class=\"tiny-share-widget\" data-id=\"1018801\" data-linked=\"Restoration Hardware (RH +25.5%) leaps higher after &quot;updating&quot; its Q1 outlook. RH now sees...\" data-tweet=\"$RH - Restoration Hardware (RH +25.5%) leaps higher after &quot;updating&quot; its Q1 outlook. RH now sees revenues coming in between $295M and $300M (growth of 35-38%) compared to previous guidance of $280-285M (consensus is $284.6M). Additionally, the company s... https://seekingalpha.com/news/1018801?source=tweet\" data-url=\"https://seekingalpha.com/news/1018801\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:38 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1018771\" data-ts=\"1368199572\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DDD\" target=\"_blank\">DDD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1018771\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">3D Systems (DDD -2%) recoups the majority of the premarket losses it saw on news it has priced...</a></h4><p>3D Systems (<a href=\"https://seekingalpha.com/symbol/DDD\" title=\"3D Systems Corp.\">DDD</a> <font color=\"red\">-2%</font>) recoups the majority of the <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/1018381\">premarket losses</a> it saw on news it has priced its stock offering at $40, and is now trading more than 5% above the offering price. A likely factor: Janney has <a target=\"_blank\" href=\"http://www.streetinsider.com/New+Coverage/Janney+Montgomery+Scott+Starts+3D+Systems+%28DDD%29+at+Buy/8324794.html\">launched coverage</a> with a Buy and $56 PT. The firm <a target=\"_blank\" href=\"http://www.streetinsider.com/New+Coverage/Janney+Montgomery+Scott+Starts+Stratasys+Inc.+%28SSYS%29+at+Buy/8324809.html\">has also launched coverage</a> on rival Stratasys (<a href=\"https://seekingalpha.com/symbol/SSYS\" title=\"Stratasys, Inc.\">SSYS</a> <font color=\"green\">+1.8%</font>) with a Buy and $101 PT.</p><div class=\"tiny-share-widget\" data-id=\"1018771\" data-linked=\"3D Systems (DDD -2%) recoups the majority of the premarket losses it saw on news it has priced...\" data-tweet=\"$DDD $DDD $SSYS - 3D Systems (DDD -2%) recoups the majority of the premarket losses it saw on news it has priced its stock offering at $40, and is now trading more than 5% above the offering price. A likely factor: Janney has launched coverage with a Bu... https://seekingalpha.com/news/1018771?source=tweet\" data-url=\"https://seekingalpha.com/news/1018771\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:26 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1018741\" data-ts=\"1368199208\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SIRO\" target=\"_blank\">SIRO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1018741\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sirona (SIRO -2.7%) slides after beating FQ2 estimates this morning, but issuing forward...</a></h4>Sirona (<a href='https://seekingalpha.com/symbol/SIRO' title='Sirona Dental Systems, Inc.'>SIRO</a> <font color=\"red\">-2.7%</font>) slides after beating <a href=\"https://seekingalpha.com/market_currents/post/1017521\" target=\"_blank\">FQ2 estimates</a> this morning, but issuing forward guidance far below Street expectations. Revenues were solid, despite some weakness in gross margin and higher R&amp;D expenses, but for FY13 it sees its EPS coming in around $3.36 - $3.43, below Street estimates of $3.46.<div class=\"tiny-share-widget\" data-id=\"1018741\" data-linked=\"Sirona (SIRO -2.7%) slides after beating FQ2 estimates this morning, but issuing forward...\" data-tweet=\"$SIRO - Sirona (SIRO -2.7%) slides after beating FQ2 estimates this morning, but issuing forward guidance far below Street expectations. Revenues were solid, despite some weakness in gross margin and higher R&amp;D expenses, but for FY13 it sees its EPS com... https://seekingalpha.com/news/1018741?source=tweet\" data-url=\"https://seekingalpha.com/news/1018741\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:20 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1018731\" data-ts=\"1368199090\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OPEN\" target=\"_blank\">OPEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1018731\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">OpenTable (OPEN +2%) rallies after Jim Cramer gives it a favorable mention (video); the Mad...</a></h4><p>OpenTable (<a href=\"https://seekingalpha.com/symbol/OPEN\" title=\"OpenTable, Inc.\">OPEN</a> <font color=\"green\">+2%</font>) rallies after Jim Cramer <a href=\"http://www.cnbc.com/id/100725433?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&amp;par=yahoo&amp;doc=100725433%7CJim+Cramer:+This+Company%27\" target=\"_blank\">gives it a favorable mention</a> (video); the <em>Mad Money</em> host declares the restaurant reservation platform faces no real competition (<a href=\"https://seekingalpha.com/currents/post/940451\" target=\"_blank\">NoWait</a> might disagree), and that its occasionally-criticized fee structure is justified by the value that it delivers to restaurants. Cramer: \"There are other companies that do the same thing, but none of them have the scope and scale to be truly competitive right now.\" Cramer's remarks come as OpenTable <a href=\"http://techcrunch.com/2013/05/09/opentable-for-android-gets-better-google-maps-integration-booked-reservations-to-calendar-and-improved-navigation/\" target=\"_blank\">revamps its Android apps</a> to provide better Google Maps/Calendar support.</p><div class=\"tiny-share-widget\" data-id=\"1018731\" data-linked=\"OpenTable (OPEN +2%) rallies after Jim Cramer gives it a favorable mention (video); the Mad...\" data-tweet=\"$OPEN - OpenTable (OPEN +2%) rallies after Jim Cramer gives it a favorable mention (video); the Mad Money host declares the restaurant reservation platform faces no real competition (NoWait might disagree), and that its occasionally-criticized fee struc... https://seekingalpha.com/news/1018731?source=tweet\" data-url=\"https://seekingalpha.com/news/1018731\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:18 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1018681\" data-ts=\"1368198291\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AIRM\" target=\"_blank\">AIRM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1018681\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Air Methods (AIRM -5.5%) trades lower today after posting a Q1 result that missed consensus...</a></h4><p>Air Methods (<a href=\"https://seekingalpha.com/symbol/AIRM\" title=\"Air Methods Corporation\">AIRM</a> <font color=\"red\">-5.5%</font>) trades lower today after posting a <a target=\"_blank\" href=\"https://seekingalpha.com/market_currents/post/1015691\">Q1 result</a> that missed consensus across the board, swing to a loss as the provider of emergency medical transport services was hurt by bad weather and a weaker mix of payers. Total revenue slipped by 6.7% Y/Y, as community-based transports fell 7%, same-base transports decreased 9%, and Air medical services revenue declined by 10%. Expenses also grew 11% to $184.1M.</p><div class=\"tiny-share-widget\" data-id=\"1018681\" data-linked=\"Air Methods (AIRM -5.5%) trades lower today after posting a Q1 result that missed consensus...\" data-tweet=\"$AIRM - Air Methods (AIRM -5.5%) trades lower today after posting a Q1 result that missed consensus across the board, swing to a loss as the provider of emergency medical transport services was hurt by bad weather and a weaker mix of payers. Total reven... https://seekingalpha.com/news/1018681?source=tweet\" data-url=\"https://seekingalpha.com/news/1018681\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:04 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1018651\" data-ts=\"1368197893\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OLED\" target=\"_blank\">OLED</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1018651\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Universal Display (PANL -12.1%) is now tumbling in the wake of its Q1 report and guidance...</a></h4>Universal Display (<a href='https://seekingalpha.com/symbol/PANL' title='Pangaea Logistics Solutions Ltd.'>PANL</a> <font color='red'>-12.1%</font>) is now tumbling in the wake of its <a href=\"https://seekingalpha.com/currents/post/1015631\" target=\"_blank\">Q1 report</a> and guidance reiteration. Investors may have wanted a guidance hike in light of strong early demand for Samsung's (<a href='https://seekingalpha.com/symbol/SSNLF' title='Samsung Electronics Co., Ltd.'>OTC:SSNLF</a>) Galaxy S4. Also: materials cost rose by $2M Q/Q, something partly attributed on the <a href=\"https://seekingalpha.com/article/1422201-universal-display-corporation-ceo-discusses-q1-2013-results-earnings-call-transcript\" target=\"_blank\">earnings call</a> to a mix shift (to green emitters?) and higher materials cost, and (in response to a question about slumping red emitter sales) PANL  admitted customers are using materials more efficiently. On the bright side, management noted reports indicate Samsung's Galaxy Note III and an LG phone will feature flexible OLEDs; both are expected in Q4. (<a href=\"https://seekingalpha.com/currents/post/1018551\" target=\"_blank\">Lumia 928</a>)<div class=\"tiny-share-widget\" data-id=\"1018651\" data-linked=\"Universal Display (PANL -12.1%) is now tumbling in the wake of its Q1 report and guidance...\" data-tweet=\"$OLED $OLED $SSNLF - Universal Display (PANL -12.1%) is now tumbling in the wake of its Q1 report and guidance reiteration. Investors may have wanted a guidance hike in light of strong early demand for Samsung&#39;s (OTC:SSNLF) Galaxy S4. Also: materials co... https://seekingalpha.com/news/1018651?source=tweet\" data-url=\"https://seekingalpha.com/news/1018651\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1018631\" data-ts=\"1368197719\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MBI\" target=\"_blank\">MBI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1018631\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MBIA&#39;s (MBI -2.1%) earnings report is a good excuse to take just a few profits after a 50%+ run...</a></h4><p>MBIA's (<a href=\"https://seekingalpha.com/symbol/MBI\" title=\"MBIA Inc.\">MBI</a> <font color=\"red\">-2.1%</font>) <a href=\"https://seekingalpha.com/currents/post/1015591\" target=\"_blank\">earnings report </a>is a good excuse to take just a few profits after a 50%+ run the past few sessions following the BofA settlement. Analysis of the company has shifted from survival assessment <a href=\"http://www.btigresearch.com/create-pdf/?url_pdf=wp-content/uploads/2013/05/MBIA-1Q132.pdf&amp;name_pdf=MBIA-1Q132&amp;id=29946\" target=\"_blank\">to future prospects</a>, writes BTIG's Mark Palmer. Key, he says, will be management plans for extracting value from MBIA Insurance. Even attaching zero value to the unit, he rates MBIA a Buy with $22 price target.</p><div class=\"tiny-share-widget\" data-id=\"1018631\" data-linked=\"MBIA&#39;s (MBI -2.1%) earnings report is a good excuse to take just a few profits after a 50%+ run...\" data-tweet=\"$MBI - MBIA&#39;s (MBI -2.1%) earnings report is a good excuse to take just a few profits after a 50%+ run the past few sessions following the BofA settlement. Analysis of the company has shifted from survival assessment to future prospects, writes BTIG&#39;s M... https://seekingalpha.com/news/1018631?source=tweet\" data-url=\"https://seekingalpha.com/news/1018631\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1018601\" data-ts=\"1368196820\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MGA\" target=\"_blank\">MGA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1018601\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Magna&#39;s (MGA +3.8%) Q1 earnings: Y/Y revenue growth, EBIT growth, and EPS growth come in...</a></h4><p>More on Magna's (<a href=\"https://seekingalpha.com/symbol/MGA\" title=\"Magna International Inc.\">MGA</a> <font color=\"green\">+3.8%</font>) <a href=\"https://seekingalpha.com/currents/post/1018561\" target=\"_blank\">Q1 earnings</a>:<span class=\"Apple-converted-space\"> </span>Y/Y revenue growth, EBIT growth, and EPS growth come in at 9%, 4%, and 8% respectively. Complete vehicle assembly sales rise 33% to $798M. FY13 outlook is strong relative to both previous guidance and consensus as MGA sees total sales of $32.6-34B for the full year against expectations of $32.77B. (PR)</p><div class=\"tiny-share-widget\" data-id=\"1018601\" data-linked=\"More on Magna&#39;s (MGA +3.8%) Q1 earnings: Y/Y revenue growth, EBIT growth, and EPS growth come in...\" data-tweet=\"$MGA - More on Magna&#39;s (MGA +3.8%) Q1 earnings: Y/Y revenue growth, EBIT growth, and EPS growth come in at 9%, 4%, and 8% respectively. Complete vehicle assembly sales rise 33% to $798M. FY13 outlook is strong relative to both previous guidance and cons... https://seekingalpha.com/news/1018601?source=tweet\" data-url=\"https://seekingalpha.com/news/1018601\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:40 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1018591\" data-ts=\"1368196554\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FST\" target=\"_blank\">FST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1018591\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Forest Oil (FST +2.7%) is upgraded to Buy from Hold at Stifel Nicolaus, which calls it &quot;a...</a></h4><p>Forest Oil (<a href=\"https://seekingalpha.com/symbol/FST\" title=\"Forest Oil Corporation\">FST</a> <font color=\"green\">+2.7%</font>) is <a href=\"http://www.streetinsider.com/Upgrades/Stifel+Nicolaus+Upgrades+Forest+Oil+%28FST%29+to+Buy/8325613.html\" target=\"_blank\">upgraded</a> to Buy from Hold at Stifel Nicolaus, which calls it \"a turnaround stock (higher risk)\" where most of the bad news is out of the way. Valuation now looks relatively attractive on a very conservative NAV basis, the firm says, and growth in production and cash flow is set to resume in H2, which should start pushing the stock higher.</p><div class=\"tiny-share-widget\" data-id=\"1018591\" data-linked=\"Forest Oil (FST +2.7%) is upgraded to Buy from Hold at Stifel Nicolaus, which calls it &quot;a...\" data-tweet=\"$FST - Forest Oil (FST +2.7%) is upgraded to Buy from Hold at Stifel Nicolaus, which calls it &quot;a turnaround stock (higher risk)&quot; where most of the bad news is out of the way. Valuation now looks relatively attractive on a very conservative NAV basis, th... https://seekingalpha.com/news/1018591?source=tweet\" data-url=\"https://seekingalpha.com/news/1018591\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:35 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1018571\" data-ts=\"1368196416\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RDNT\" target=\"_blank\">RDNT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1018571\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RadNet (RDNT -3%) slips this morning after posting a mixed Q1 beating on its top line but coming...</a></h4>RadNet (<a href='https://seekingalpha.com/symbol/RDNT' title='RadNet, Inc.'>RDNT</a> <font color=\"red\">-3%</font>) slips this morning after posting a mixed <a href=\"https://seekingalpha.com/market_currents/post/1016961\" target=\"_blank\">Q1 beating</a> on its top line but coming up short on a per share basis. Service fee revenue increased by 6.7% Y/Y, but its bottom line margins were impacted by higher acquisition and restructuring costs. Overall volume increased by 5.7%, with MRI volume <font color=\"green\">+8.6%</font>, CT volume <font color=\"red\">-2.9%</font> and PET/CT volume <font color=\"red\">-2.5%</font>.<div class=\"tiny-share-widget\" data-id=\"1018571\" data-linked=\"RadNet (RDNT -3%) slips this morning after posting a mixed Q1 beating on its top line but coming...\" data-tweet=\"$RDNT - RadNet (RDNT -3%) slips this morning after posting a mixed Q1 beating on its top line but coming up short on a per share basis. Service fee revenue increased by 6.7% Y/Y, but its bottom line margins were impacted by higher acquisition and restru... https://seekingalpha.com/news/1018571?source=tweet\" data-url=\"https://seekingalpha.com/news/1018571\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:33 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1018541\" data-ts=\"1368195974\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1018541\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tesla Motors (TSLA +14.6%) tightens its grip on the shorts, now up 43% in 2 days following...</a></h4>Tesla Motors (<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a> <font color='green'>+14.6%</font>) tightens its grip on the shorts, now up 43% in 2 days following Wednesday's earnings. Ivan Hoff extrapolates into the future and suggests Tesla could be <a href=\"http://ivanhoff.com/2013/05/10/tesla-motors-could-be-a-100-billion-dollar-company-in-10-years/\" target=\"_blank\">a $100B company</a> in 10 years (that's all?). Musk's SolarCity (SCTY <font color='green'>+9.4%</font>) gains as well.<div class=\"tiny-share-widget\" data-id=\"1018541\" data-linked=\"Tesla Motors (TSLA +14.6%) tightens its grip on the shorts, now up 43% in 2 days following...\" data-tweet=\"$TSLA - Tesla Motors (TSLA +14.6%) tightens its grip on the shorts, now up 43% in 2 days following Wednesday&#39;s earnings. Ivan Hoff extrapolates into the future and suggests Tesla could be a $100B company in 10 years (that&#39;s all?). Musk&#39;s SolarCity (SCTY... https://seekingalpha.com/news/1018541?source=tweet\" data-url=\"https://seekingalpha.com/news/1018541\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1018531\" data-ts=\"1368195789\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MCPIQ\" target=\"_blank\">MCPIQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1018531\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">A new processing facility at Molycorp&#39;s (MCP +20.5%) Mountain Pass mine should reach full...</a></h4><p>A new processing facility at Molycorp's (MCP <font color=\"green\">+20.5%</font>) Mountain Pass mine should <a href=\"http://www.reuters.com/article/2013/05/09/molycorp-results-idUSL2N0DQ3AC20130509\" target=\"_blank\">reach full production by mid-year</a>, but a chlor-alkali plant at the mine that would allow for cost cuts by recycling some chemicals is not due to start operating until later in the year, MCP says in last night's <a href=\"https://seekingalpha.com/article/1421801-molycorp-s-ceo-discusses-q1-2013-results-earnings-call-transcript\" target=\"_blank\">conference call</a>. MCP will be unable to sufficiently cut costs until the plant is online, so it may cut production at the processing plant.</p><div class=\"tiny-share-widget\" data-id=\"1018531\" data-linked=\"A new processing facility at Molycorp&#39;s (MCP +20.5%) Mountain Pass mine should reach full...\" data-tweet=\"$MCPIQ - A new processing facility at Molycorp&#39;s (MCP +20.5%) Mountain Pass mine should reach full production by mid-year, but a chlor-alkali plant at the mine that would allow for cost cuts by recycling some chemicals is not due to start operating unti... https://seekingalpha.com/news/1018531?source=tweet\" data-url=\"https://seekingalpha.com/news/1018531\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1018511\" data-ts=\"1368194860\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/COHN\" target=\"_blank\">COHN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1018511\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Risk still exists. Institutional Financial Markets (IFMI -33.6%) gets smacked after reporting a...</a></h4><p>Risk still exists. Institutional Financial Markets (IFMI <font color=\"red\">-33.6%</font>) gets smacked after reporting a Q1 loss of $0.34/share, undertaking a dilutive capital raise, and adopting a poison pill in which it threatens significant dilution to any group acquiring more than 4.95% of the company's stock without board approval.</p><div class=\"tiny-share-widget\" data-id=\"1018511\" data-linked=\"Risk still exists. Institutional Financial Markets (IFMI -33.6%) gets smacked after reporting a...\" data-tweet=\"$COHN - Risk still exists. Institutional Financial Markets (IFMI -33.6%) gets smacked after reporting a Q1 loss of $0.34/share, undertaking a dilutive capital raise, and adopting a poison pill in which it threatens significant dilution to any group acqu... https://seekingalpha.com/news/1018511?source=tweet\" data-url=\"https://seekingalpha.com/news/1018511\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1018501\" data-ts=\"1368194627\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MT\" target=\"_blank\">MT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1018501\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ArcelorMittal (MT +4%) opens higher after posting a strong operational quarter despite the...</a></h4><p>ArcelorMittal (<a href=\"https://seekingalpha.com/symbol/MT\" title=\"ArcelorMittal\">MT</a> <font color=\"green\">+4%</font>) opens higher after posting a <a href=\"https://seekingalpha.com/currents/post/1016881\" target=\"_blank\">strong operational quarter</a> despite the difficult environment. Liquidity increased to $18B from $14.5B Q/Q, and net debt  fell by $3.8B due primarily to capital market transactions and proceeds from asset sales. Full-year EBITDA guidance of $7.1B is  unchanged, though it assumes iron ore prices and steel margins over raw  materials are similar to 2012 levels.</p><div class=\"tiny-share-widget\" data-id=\"1018501\" data-linked=\"ArcelorMittal (MT +4%) opens higher after posting a strong operational quarter despite the...\" data-tweet=\"$MT - ArcelorMittal (MT +4%) opens higher after posting a strong operational quarter despite the difficult environment. Liquidity increased to $18B from $14.5B Q/Q, and net debt fell by $3.8B due primarily to capital market transactions and proceeds fro... https://seekingalpha.com/news/1018501?source=tweet\" data-url=\"https://seekingalpha.com/news/1018501\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:03 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1018461\" data-ts=\"1368193795\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ROSG-OLD\" target=\"_blank\">ROSG-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1018461\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rosetta Genomics (ROSG-OLD +0.6%) rises after saying it has received a $665K negotiated...</a></h4><p>Rosetta Genomics (<a href=\"https://seekingalpha.com/symbol/ROSG-OLD\" title=\"Rosetta Genomics Ltd.\">ROSG-OLD</a> <font color=\"green\">+0.6%</font>) rises after saying it has received a $665K negotiated settlement payment from Sanra Labs in connection with ROSG's sale of Parkway Clinical Laboratories. (PR)</p><div class=\"tiny-share-widget\" data-id=\"1018461\" data-linked=\"Rosetta Genomics (ROSG-OLD +0.6%) rises after saying it has received a $665K negotiated...\" data-tweet=\"$ROSG-OLD - Rosetta Genomics (ROSG-OLD +0.6%) rises after saying it has received a $665K negotiated settlement payment from Sanra Labs in connection with ROSG&#39;s sale of Parkway Clinical Laboratories. (PR) https://seekingalpha.com/news/1018461?source=tweet\" data-url=\"https://seekingalpha.com/news/1018461\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:49 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1018451\" data-ts=\"1368193737\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SINA\" target=\"_blank\">SINA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1018451\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">An upgrade to Buy from Goldman&#39;s Piyush Mubayi helps Sina (SINA +2.6%) open higher. Mubayi...</a></h4><a href=\"http://www.streetinsider.com/Upgrades/Tech+Giants+Battle+in+China%3B+Goldman+Upgrades+SINA+%28SINA%29+to+Buy/8326080.html\" target=\"_blank\">An upgrade to Buy</a> from Goldman's Piyush Mubayi helps Sina (<a href=\"https://seekingalpha.com/symbol/SINA\" title=\"Sina Corporation\">SINA</a> <font color=\"green\">+2.6%</font>) open higher. Mubayi expects <a href=\"https://seekingalpha.com/currents/post/977461\" target=\"_blank\">the Alibaba deal</a> to \"enable Alibaba to direct [e-commerce] demand to Weibo,\" thereby improving monetization. Talking more broadly about the Chinese Web services space, he declares Alibaba, Baidu (NASDAQ:<a href=\"https://seekingalpha.com/symbol/BIDU\" title=\"Baidu, Inc.\">BIDU</a>), and Tencent (<a href=\"https://seekingalpha.com/symbol/TCEHY\" title=\"Tencent Holding Ltd. ADR\">OTCPK:TCEHY</a>) to be in a 3-way leadership battle that \"will likely shape the industry landscape over the next 5-10 years.\" Other recent deals (<a href=\"https://seekingalpha.com/currents/post/1003271\" target=\"_blank\">I</a>, <a href=\"https://seekingalpha.com/currents/post/1018351\" target=\"_blank\">II</a>) also seem to bear that out. Will Baidu make a deal or two to strengthen its social networking hand in this battle? (<a href=\"https://seekingalpha.com/currents/post/982401\" target=\"_blank\">Jefferies Sina upgrade</a>)<div class=\"tiny-share-widget\" data-id=\"1018451\" data-linked=\"An upgrade to Buy from Goldman&#39;s Piyush Mubayi helps Sina (SINA +2.6%) open higher. Mubayi...\" data-tweet=\"$SINA $SINA $BIDU - An upgrade to Buy from Goldman&#39;s Piyush Mubayi helps Sina (SINA +2.6%) open higher. Mubayi expects the Alibaba deal to &quot;enable Alibaba to direct [e-commerce] demand to Weibo,&quot; thereby improving monetization. Talking more broadly abou... https://seekingalpha.com/news/1018451?source=tweet\" data-url=\"https://seekingalpha.com/news/1018451\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:48 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1018421\" data-ts=\"1368193180\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OPTR\" target=\"_blank\">OPTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1018421\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Optimer&#39;s (OPTR -8.2%) Q1 results: Dificid net sales of $16.8M versus $14.4M in Q1 2012....</a></h4><p>More on Optimer's (<a href=\"https://seekingalpha.com/symbol/OPTR\" title=\"Optimer Pharmaceuticals, Inc.\">OPTR</a> <font color=\"red\">-8.2%</font>) <a href=\"https://seekingalpha.com/currents/post/1015511\" target=\"_blank\">Q1 results</a>: Dificid net sales of $16.8M versus $14.4M in Q1 2012. The company sees a 5% increase in demand for the product but Needham's Alan Carr notes that consensus estimates were for Dificid sales of $20M and worries that the \"concerning\" sales trajectory (0% growth Q/Q) could <a href=\"http://www.streetinsider.com/Downgrades/Needham+%26+Company+Downgrades+Optimer+Pharmaceuticals+%28OPTR%29+to+Hold+on+Weaker+Dificid+Sales%3B+Says+Takeover+Hopes+Dim/8325653.html\" target=\"_blank\">reduce the premium</a> any potential suitor might be willing to pay to acquire the company. (PR)</p><div class=\"tiny-share-widget\" data-id=\"1018421\" data-linked=\"More on Optimer&#39;s (OPTR -8.2%) Q1 results: Dificid net sales of $16.8M versus $14.4M in Q1 2012....\" data-tweet=\"$OPTR - More on Optimer&#39;s (OPTR -8.2%) Q1 results: Dificid net sales of $16.8M versus $14.4M in Q1 2012. The company sees a 5% increase in demand for the product but Needham&#39;s Alan Carr notes that consensus estimates were for Dificid sales of $20M and w... https://seekingalpha.com/news/1018421?source=tweet\" data-url=\"https://seekingalpha.com/news/1018421\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:39 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1018381\" data-ts=\"1368192408\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DDD\" target=\"_blank\">DDD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1018381\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">3D Systems (NYSE:DDD) -5.9% to $40.48 after pricing a 7.5M-share stock offering at $40. 6.2M...</a></h4><p>3D Systems (NYSE:<a href=\"https://seekingalpha.com/symbol/DDD\" title=\"3D Systems Corp.\">DDD</a>) <font color=\"red\">-5.9%</font> to $40.48 after pricing a 7.5M-share stock offering at $40. 6.2M shares were issued by the company, and 1.3M sold by existing investors (inc. insiders). 3D expects net proceeds of $237M. (PR) (<a href=\"https://seekingalpha.com/currents/post/1006201\" target=\"_blank\">previous</a>)</p><div class=\"tiny-share-widget\" data-id=\"1018381\" data-linked=\"3D Systems (NYSE:DDD) -5.9% to $40.48 after pricing a 7.5M-share stock offering at $40. 6.2M...\" data-tweet=\"$DDD - 3D Systems (NYSE:DDD) -5.9% to $40.48 after pricing a 7.5M-share stock offering at $40. 6.2M shares were issued by the company, and 1.3M sold by existing investors (inc. insiders). 3D expects net proceeds of $237M. (PR) (previous) https://seekingalpha.com/news/1018381?source=tweet\" data-url=\"https://seekingalpha.com/news/1018381\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:26 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1018361\" data-ts=\"1368191934\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ISRG\" target=\"_blank\">ISRG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1018361\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intuitive Surgical (NASDAQ:ISRG) issues &quot;urgent medical device notification&quot; regarding...</a></h4><p>Intuitive Surgical (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ISRG\" title=\"Intuitive Surgical, Inc.\">ISRG</a>) issues \"urgent medical device notification\" regarding \"micro-cracks\" (which the company warns may not be visible to the naked eye) in mono polar curved scissors that could result in leaks, creating a \"pathway for electrosurgical energy\" to reach tissue, causing \"thermal injury\" (i.e. burns). Shares <font color=\"red\">-2.63%</font> premarket. (<a href=\"http://www.cnbc.com/id/100726886\" target=\"_blank\">Herb Greenberg</a>)</p><div class=\"tiny-share-widget\" data-id=\"1018361\" data-linked=\"Intuitive Surgical (NASDAQ:ISRG) issues &quot;urgent medical device notification&quot; regarding...\" data-tweet=\"$ISRG - Intuitive Surgical (NASDAQ:ISRG) issues &quot;urgent medical device notification&quot; regarding &quot;micro-cracks&quot; (which the company warns may not be visible to the naked eye) in mono polar curved scissors that could result in leaks, creating a &quot;pathway for... https://seekingalpha.com/news/1018361?source=tweet\" data-url=\"https://seekingalpha.com/news/1018361\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1018131\" data-ts=\"1368191429\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PGNX\" target=\"_blank\">PGNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1018131\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket gainers: PGNX +26%. UNIS +21%. UBNT +19%. SQNM +11%. MCP +11%. XIN +7%. NBG +6%. NTE...</a></h4><b>Premarket gainers:</b> <a href=\"https://seekingalpha.com/symbol/PGNX\" title=\"Progenics Pharmaceuticals Inc.\">PGNX</a> <font color=\"green\">+26%</font>. <a href=\"https://seekingalpha.com/symbol/UNIS\" title=\"Unilife Corporation\">UNIS</a> <font color=\"green\">+21%</font>. <a href=\"https://seekingalpha.com/symbol/UBNT\" title=\"Ubiquiti Networks, Inc.\">UBNT</a> <font color=\"green\">+19%</font>. <a href=\"https://seekingalpha.com/symbol/SQNM\" title=\"Sequenom, Inc.\">SQNM</a> <font color=\"green\">+11%</font>. MCP <font color=\"green\">+11%</font>. <a href=\"https://seekingalpha.com/symbol/XIN\" title=\"Xinyuan Real Estate Co., Ltd.\">XIN</a> <font color=\"green\">+7%</font>. NBG <font color=\"green\">+6%</font>. NTE <font color=\"green\">+5%</font>. <a href=\"https://seekingalpha.com/symbol/MT\" title=\"ArcelorMittal\">MT</a> <font color=\"green\">+5%</font>. <br> <b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/PTIE\" title=\"Pain Therapeutics\">PTIE</a> <font color=\"red\">-48%</font>. IFMI <font color=\"red\">-36%</font>. <a href=\"https://seekingalpha.com/symbol/AFFY\" title=\"Affymax, Inc.\">OTC:AFFY</a> <font color=\"red\">-18%</font>. <a href=\"https://seekingalpha.com/symbol/SNTS\" title=\"Santarus, Inc.\">SNTS</a> <font color=\"red\">-7%</font>. <a href=\"https://seekingalpha.com/symbol/OPTR\" title=\"Optimer Pharmaceuticals, Inc.\">OPTR</a> <font color=\"red\">-7%</font>. <a href=\"https://seekingalpha.com/symbol/DDD\" title=\"3D Systems Corp.\">DDD</a> <font color=\"red\">-6%</font>. <a href=\"https://seekingalpha.com/symbol/MDRX\" title=\"Allscripts Healthcare Solutions, Inc.\">MDRX</a> <font color=\"red\">-6%</font>. <a href=\"https://seekingalpha.com/symbol/LFVN\" title=\"LifeVantage Corporation\">LFVN</a> <font color=\"red\">-5%</font>.<div class=\"tiny-share-widget\" data-id=\"1018131\" data-linked=\"Premarket gainers: PGNX +26%. UNIS +21%. UBNT +19%. SQNM +11%. MCP +11%. XIN +7%. NBG +6%. NTE...\" data-tweet=\"$PGNX $PGNX $UNIS - Premarket gainers: PGNX +26%. UNIS +21%. UBNT +19%. SQNM +11%. MCP +11%. XIN +7%. NBG +6%. NTE +5%. MT +5%. Losers: PTIE -48%. IFMI -36%. OTC:AFFY -18%. SNTS -7%. OPTR -7%. DDD -6%. MDRX -6%. LFVN -5%. https://seekingalpha.com/news/1018131?source=tweet\" data-url=\"https://seekingalpha.com/news/1018131\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1018031\" data-ts=\"1368190724\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PGNX\" target=\"_blank\">PGNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1018031\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Progenics&#39; (NASDAQ:PGNX) earnings: Relistor sales rise 47% Q/Q and fall 37% Y/Y, as...</a></h4><p>More on Progenics' (NASDAQ:<a href=\"https://seekingalpha.com/symbol/PGNX\" title=\"Progenics Pharmaceuticals Inc.\">PGNX</a>) <a href=\"https://seekingalpha.com/currents/post/1017681\" target=\"_blank\">earnings</a>: Relistor sales rise 47% Q/Q and fall 37% Y/Y, as royalties were $1.2M in Q1 compared to $1.8M in Q1 2012. Data from Salix (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SLXP\" title=\"Salix Pharmaceuticals, Ltd.\">SLXP</a>) (which said on its <a href=\"https://seekingalpha.com/article/1422021-salix-pharmaceuticals-management-discusses-q1-2013-results-earnings-call-transcript?source=google_news\" target=\"_blank\">CC</a> that prescription growth increased 52% Y/Y) including the regional breakdown, shows Relistor net sales of $6.7M in the U.S. and $1M outside the country. SLXP also notes that it believes a path forward for the drug (in terms of expanding its indications) \"could be reached with the FDA\" this year. PGNX shares <font color=\"green\">+21%</font> premarket. (PR)</p><div class=\"tiny-share-widget\" data-id=\"1018031\" data-linked=\"More on Progenics&#39; (NASDAQ:PGNX) earnings: Relistor sales rise 47% Q/Q and fall 37% Y/Y, as...\" data-tweet=\"$PGNX $PGNX $SLXP - More on Progenics&#39; (NASDAQ:PGNX) earnings: Relistor sales rise 47% Q/Q and fall 37% Y/Y, as royalties were $1.2M in Q1 compared to $1.8M in Q1 2012. Data from Salix (NASDAQ:SLXP) (which said on its CC that prescription growth increas... https://seekingalpha.com/news/1018031?source=tweet\" data-url=\"https://seekingalpha.com/news/1018031\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1017991\" data-ts=\"1368190153\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BKNG\" target=\"_blank\">BKNG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1017991\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Priceline (PCLN) recover from a post-earnings dip and are now trading level in...</a></h4><p>Shares of Priceline (PCLN) recover from a post-earnings dip and are now trading level in premarket action. A number of investment firms are out with positive comments and minor price target bumps which appear to be reversing sentiment after the company's revenue guidance came in below estimates. (<a href=\"http://cms.seekingalpha.com/currents/post/1015491\" target=\"_blank\">earnings</a>, <a href=\"https://seekingalpha.com/currents/post/1016581\" target=\"_blank\">conference call wrapup</a>)</p><div class=\"tiny-share-widget\" data-id=\"1017991\" data-linked=\"Shares of Priceline (PCLN) recover from a post-earnings dip and are now trading level in...\" data-tweet=\"$BKNG - Shares of Priceline (PCLN) recover from a post-earnings dip and are now trading level in premarket action. A number of investment firms are out with positive comments and minor price target bumps which appear to be reversing sentiment after the ... https://seekingalpha.com/news/1017991?source=tweet\" data-url=\"https://seekingalpha.com/news/1017991\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:49 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1017911\" data-ts=\"1368188952\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DRRX\" target=\"_blank\">DRRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1017911\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">The sell-off in shares of Durect (NASDAQ:DRRX) has accelerated meaningfully as the stock is now...</a></h4><p>The sell-off in shares of Durect (NASDAQ:<a href=\"https://seekingalpha.com/symbol/DRRX\" title=\"Durect Corporation\">DRRX</a>) has accelerated meaningfully as the stock is now down <font color=\"red\"><b>37%</b></font> premarket after Pfizer's <a href=\"https://seekingalpha.com/currents/post/1017621\" target=\"_blank\">Remoxy comments</a>. Reminder: DRRX is entitled to royalties of between 6% and 11.5% of potential Remoxy net sales which some analysts have said could ultimately hit $1B if the drug reaches market. The impact for DRRX, which only had $53.1M in total revenue in 2012, really cannot be overstated. See SA contributor PropThink's <a href=\"https://seekingalpha.com/article/1398941-durect-pfizer-hints-at-progress-with-remoxy\" target=\"_blank\">recent analysis</a> for more. (Also: PTIE <a href=\"https://seekingalpha.com/currents/post/1017851\" target=\"_blank\">crashes</a> on PFE comments)</p><div class=\"tiny-share-widget\" data-id=\"1017911\" data-linked=\"The sell-off in shares of Durect (NASDAQ:DRRX) has accelerated meaningfully as the stock is now...\" data-tweet=\"$DRRX - The sell-off in shares of Durect (NASDAQ:DRRX) has accelerated meaningfully as the stock is now down 37% premarket after Pfizer&#39;s Remoxy comments. Reminder: DRRX is entitled to royalties of between 6% and 11.5% of potential Remoxy net sales whic... https://seekingalpha.com/news/1017911?source=tweet\" data-url=\"https://seekingalpha.com/news/1017911\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1017881\" data-ts=\"1368188256\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GFI\" target=\"_blank\">GFI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1017881\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Gold Fields&#39; (NYSE:GFI)&amp;nbsp;Q1 results: Reports operating margin of 50% and NCE margin...</a></h4><p>More on Gold Fields' (NYSE:<a href=\"https://seekingalpha.com/symbol/GFI\" title=\"Gold Fields Limited\">GFI</a>) <a href=\"https://seekingalpha.com/currents/post/1017821\" target=\"_blank\">Q1 results</a>: Reports operating margin of 50% and NCE margin of 21%. Says it will cut 2013 spending on exploration to $80M from ~$130M in 2012, focusing on smaller, higher grade and less capital intensive projects. Shares <font color=\"red\">-3.2%</font> premarket.</p><div class=\"tiny-share-widget\" data-id=\"1017881\" data-linked=\"More on Gold Fields&#39; (NYSE:GFI) Q1 results: Reports operating margin of 50% and NCE margin of...\" data-tweet=\"$GFI - More on Gold Fields&#39; (NYSE:GFI) Q1 results: Reports operating margin of 50% and NCE margin of 21%. Says it will cut 2013 spending on exploration to $80M from ~$130M in 2012, focusing on smaller, higher grade and less capital intensive projects. S... https://seekingalpha.com/news/1017881?source=tweet\" data-url=\"https://seekingalpha.com/news/1017881\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1017871\" data-ts=\"1368188230\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DNDN\" target=\"_blank\">DNDN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1017871\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dendreon&#39;s (NASDAQ:DNDN) price target is shaved to $1 by BAML&#39;s Rachael McMinn (the axe,...</a></h4><p>Dendreon's (NASDAQ:<a href=\"https://seekingalpha.com/symbol/DNDN\" title=\"Dendreon Corporation\">DNDN</a>) price target is <a href=\"https://twitter.com/thenotablecalls/status/332828208254840832\" target=\"_blank\">shaved to $1</a> by BAML's Rachael McMinn (<a href=\"https://twitter.com/thenotablecalls/status/332827785351544833\" target=\"_blank\">the axe</a>, according to Notable Calls), who says even this doesn't take into account additional potential dilution. The company's underwater $648M in convertible debt with \"no clear path to profitability provides a serious challenge to keep the business in operation beyond 2014.\" More: <a href=\"https://twitter.com/thenotablecalls/status/332829607327838208\" target=\"_blank\">Citi downgrades</a> to Sell with $3 PT, and <a href=\"https://twitter.com/thenotablecalls/status/332830379817959424\" target=\"_blank\">Blair cuts</a> its PT to $2. Shares <font color=\"red\">-4.2%</font> to $3.86 premarket.</p><div class=\"tiny-share-widget\" data-id=\"1017871\" data-linked=\"Dendreon&#39;s (NASDAQ:DNDN) price target is shaved to $1 by BAML&#39;s Rachael McMinn (the axe,...\" data-tweet=\"$DNDN - Dendreon&#39;s (NASDAQ:DNDN) price target is shaved to $1 by BAML&#39;s Rachael McMinn (the axe, according to Notable Calls), who says even this doesn&#39;t take into account additional potential dilution. The company&#39;s underwater $648M in convertible debt ... https://seekingalpha.com/news/1017871?source=tweet\" data-url=\"https://seekingalpha.com/news/1017871\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1017851\" data-ts=\"1368187945\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTIE\" target=\"_blank\">PTIE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1017851\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pain Therapeutics (NASDAQ:PTIE) craters 45.5% in premarket trading after Pfizer (NYSE:PFE) says...</a></h4><p>Pain Therapeutics (NASDAQ:<a href=\"https://seekingalpha.com/symbol/PTIE\" title=\"Pain Therapeutics\">PTIE</a>) craters <font color=\"red\"><b>45.5%</b></font> in premarket trading after Pfizer (NYSE:<a href=\"https://seekingalpha.com/symbol/PFE\" title=\"Pfizer Inc.\">PFE</a>) says it is \"<a href=\"https://seekingalpha.com/currents/post/1017621\" target=\"_blank\">considering its options</a>\" on Remoxy and may not respond to the FDA's complete response letter anytime in the next two years. PTIE sub-licensed Remoxy's commercialization rights to PFE subsidiary King Pharma (<a href=\"https://seekingalpha.com/currents/post/982661\" target=\"_blank\">I</a>, <a href=\"https://seekingalpha.com/currents/post/948421\" target=\"_blank\">II</a>).</p><div class=\"tiny-share-widget\" data-id=\"1017851\" data-linked=\"Pain Therapeutics (NASDAQ:PTIE) craters 45.5% in premarket trading after Pfizer (NYSE:PFE) says...\" data-tweet=\"$PTIE $SAVA $PFE - Pain Therapeutics (NASDAQ:PTIE) craters 45.5% in premarket trading after Pfizer (NYSE:PFE) says it is &quot;considering its options&quot; on Remoxy and may not respond to the FDA&#39;s complete response letter anytime in the next two years. PTIE su... https://seekingalpha.com/news/1017851?source=tweet\" data-url=\"https://seekingalpha.com/news/1017851\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:12 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1017821\" data-ts=\"1368187691\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GFI\" target=\"_blank\">GFI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1017821\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gold Fields (NYSE:GFI): Q1 EPS of $0.09 misses by $0.03. Gold production down 11% to 477K...</a></h4><strong>Gold Fields (NYSE:<a href=\"https://seekingalpha.com/symbol/GFI\" title=\"Gold Fields Limited\">GFI</a>):</strong> Q1 EPS of $0.09 <font color=\"red\">misses by $0.03</font>. Gold production down 11% to 477K equivalent attributable oz. Shares <font color=\"red\">-3.2%</font> premarket. (PR)<div class=\"tiny-share-widget\" data-id=\"1017821\" data-linked=\"Gold Fields (NYSE:GFI): Q1 EPS of $0.09 misses by $0.03. Gold production down 11% to 477K...\" data-tweet=\"$GFI - Gold Fields (NYSE:GFI): Q1 EPS of $0.09 misses by $0.03. Gold production down 11% to 477K equivalent attributable oz. Shares -3.2% premarket. (PR) https://seekingalpha.com/news/1017821?source=tweet\" data-url=\"https://seekingalpha.com/news/1017821\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:08 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1017621\" data-ts=\"1368186390\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PFE\" target=\"_blank\">PFE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1017621\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pfizer (NYSE:PFE) updates Durect (NASDAQ:DRRX) on Remoxy, saying that it&#39;s &quot;considering its...</a></h4><p>Pfizer (NYSE:<a href=\"https://seekingalpha.com/symbol/PFE\" title=\"Pfizer Inc.\">PFE</a>) updates Durect (NASDAQ:<a href=\"https://seekingalpha.com/symbol/DRRX\" title=\"Durect Corporation\">DRRX</a>) on Remoxy, saying that it's \"considering its options\", and that if it elects to continue development of Remoxy, \"we would not expect to submit a response to the \"complete response\" letter before mid-2015.\" (PR) This is less positive than <a href=\"https://seekingalpha.com/article/1398941-durect-pfizer-hints-at-progress-with-remoxy\" target=\"_blank\">expected by SA author Jason Napodano</a>; shares are <font color=\"red\">-12.6%</font> premarket.</p><div class=\"tiny-share-widget\" data-id=\"1017621\" data-linked=\"Pfizer (NYSE:PFE) updates Durect (NASDAQ:DRRX) on Remoxy, saying that it&#39;s &quot;considering its...\" data-tweet=\"$PFE $PFE $DRRX - Pfizer (NYSE:PFE) updates Durect (NASDAQ:DRRX) on Remoxy, saying that it&#39;s &quot;considering its options&quot;, and that if it elects to continue development of Remoxy, &quot;we would not expect to submit a response to the &quot;complete response&quot; letter ... https://seekingalpha.com/news/1017621?source=tweet\" data-url=\"https://seekingalpha.com/news/1017621\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1017601\" data-ts=\"1368186101\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1017601\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">The Australian dollar (FXA) sinks below parity with the greenback for the first time since last...</a></h4><p>The Australian dollar (<a href=\"https://seekingalpha.com/symbol/fxa\" title=\"CurrencyShares Australian Dollar Trust ETF\">FXA</a>) sinks below parity with the greenback <a href=\"http://finviz.com/forex_charts.ashx?t=AUDUSD&amp;tf=d1\" target=\"_blank\">for the first time</a> since last June, a victim of a slowdown in the Aussie economy and weak commodity prices (the two are surely intertwined). Aussie stocks are rising along with the rest of the world, but the Australian Index Fund ETF (<a href=\"https://seekingalpha.com/symbol/ewa\" title=\"iShares MSCI Australia Index Fund\">EWA</a>) - unhedged against the currency - <a href=\"http://I9yMUeDIB4LE0gHTWQ\" target=\"_blank\">is lagging</a>.</p><div class=\"tiny-share-widget\" data-id=\"1017601\" data-linked=\"The Australian dollar (FXA) sinks below parity with the greenback for the first time since last...\" data-tweet=\"$FXA $EWA $EWAS - The Australian dollar (FXA) sinks below parity with the greenback for the first time since last June, a victim of a slowdown in the Aussie economy and weak commodity prices (the two are surely intertwined). Aussie stocks are rising alo... https://seekingalpha.com/news/1017601?source=tweet\" data-url=\"https://seekingalpha.com/news/1017601\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1017581\" data-ts=\"1368185637\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1017581\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">The stronger dollar has precious metals resuming their decline in force (or is the decline in...</a></h4><p>The stronger dollar has precious metals resuming their decline in force (or is the decline in precious metals strengthening the dollar), with gold (<a href=\"https://seekingalpha.com/symbol/gld\" title=\"SPDR Gold Trust ETF\">GLD</a>) <font color=\"red\">off 2.3%</font> and silver (<a href=\"https://seekingalpha.com/symbol/slv\" title=\"iShares Silver Trust ETF\">SLV</a>) <font color=\"red\">off 2.2%</font>. Crude oil (<a href=\"https://seekingalpha.com/symbol/uso\" title=\"The United States Oil ETF, LP\">USO</a>) pulls back a bit from its recent big rally, <font color=\"red\">-0.9%</font> to $95.53.</p><div class=\"tiny-share-widget\" data-id=\"1017581\" data-linked=\"The stronger dollar has precious metals resuming their decline in force (or is the decline in...\" data-tweet=\"$GLD $SLV $USO - The stronger dollar has precious metals resuming their decline in force (or is the decline in precious metals strengthening the dollar), with gold (GLD) off 2.3% and silver (SLV) off 2.2%. Crude oil (USO) pulls back a bit from its recen... https://seekingalpha.com/news/1017581?source=tweet\" data-url=\"https://seekingalpha.com/news/1017581\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>63&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1017561\" data-ts=\"1368185273\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APO\" target=\"_blank\">APO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1017561\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Selling everything &quot;not nailed down,&quot; indeed. Apollo Global Management (NYSE:APO) prices a 21.1M...</a></h4><p>Selling everything <a href=\"https://seekingalpha.com/currents/post/999001\" target=\"_blank\">\"not nailed down,\"</a> indeed. Apollo Global Management (NYSE:<a href=\"https://seekingalpha.com/symbol/APO\" title=\"Apollo Global Management, LLC\">APO</a>) prices a 21.1M share secondary offered by strategic investors and certain managing partners at $25/share. Shares <font color=\"red\">-3.2%</font> premarket to $24.77, now off <font color=\"red\">more than 11%</font> since the post-earnings pop on Monday morning. (PR)</p><div class=\"tiny-share-widget\" data-id=\"1017561\" data-linked=\"Selling everything &quot;not nailed down,&quot; indeed. Apollo Global Management (NYSE:APO) prices a 21.1M...\" data-tweet=\"$APO - Selling everything &quot;not nailed down,&quot; indeed. Apollo Global Management (NYSE:APO) prices a 21.1M share secondary offered by strategic investors and certain managing partners at $25/share. Shares -3.2% premarket to $24.77, now off more than 11% si... https://seekingalpha.com/news/1017561?source=tweet\" data-url=\"https://seekingalpha.com/news/1017561\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:27 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1017271\" data-ts=\"1368182439\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NXST\" target=\"_blank\">NXST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1017271\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Forget Nexstar&#39;s (NASDAQ:NXST) Q1 results, Wells Fargo says, &quot;the big news was the $5/share FCF...</a></h4><p>Forget Nexstar's (NASDAQ:<a href=\"https://seekingalpha.com/symbol/NXST\" title=\"Nexstar Media Group, Inc.\">NXST</a>) <a href=\"https://seekingalpha.com/currents/post/1007941\" target=\"_blank\">Q1 results</a>, Wells Fargo says, \"the big news was the $5/share FCF number that NXST threw out\" on <a href=\"http://goo.gl/RvTiA\" target=\"_blank\">its earnings call</a>, building on its acquisition of CCA Group. Once the consolidation is complete, firm wouldn't be surprised \"to see NXST increase its capital return payout ratio significantly.\" Shares were <font color=\"green\">+4.85%</font> yesterday, and <b><font color=\"green\">+169%</font></b> YTD.</p><div class=\"tiny-share-widget\" data-id=\"1017271\" data-linked=\"Forget Nexstar&#39;s (NASDAQ:NXST) Q1 results, Wells Fargo says, &quot;the big news was the $5/share FCF...\" data-tweet=\"$NXST - Forget Nexstar&#39;s (NASDAQ:NXST) Q1 results, Wells Fargo says, &quot;the big news was the $5/share FCF number that NXST threw out&quot; on its earnings call, building on its acquisition of CCA Group. Once the consolidation is complete, firm wouldn&#39;t be surp... https://seekingalpha.com/news/1017271?source=tweet\" data-url=\"https://seekingalpha.com/news/1017271\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:40 AM </div></div></li>","count":71,"message":null,"success":true,"today":{"start":1576818000,"end":1576904399,"str":"Friday, December 20, 2019"},"yesterday":{"start":1576731600,"end":1576817999}}